{
"generated_at": "2026-07-09T16:24:01+08:00",
"market_date": "2026-07-08",
"universe_count": 1981,
"scored_count": 514,
"candidate_count": 522,
"hot_seed": 120,
"macro": {
"regime": "risk_off",
"regime_raw": -0.03600346942211634,
"spy_return_5d": -0.0018345609509704541,
"spy_return_20d": 0.008360236405760446,
"qqq_return_5d": -0.033894651201996306,
"vix_level": 16.59000015258789,
"vix_return_5d": 0.0,
"tnx_return_5d": 0.04458154814654369,
"summary_en": "Regime=risk_off; SPY 5d -0.2% / 20d +0.8%; VIX≈16.6 (5d +0.0%).",
"summary_zh": "宏观体制：偏避险。SPY 5日 -0.2% / 20日 +0.8%；VIX≈16.6（5日 +0.0%）。",
"themes": {
"monetary_policy": 0.16666666666666666,
"commodities": 0.4166666666666667,
"market": 0.3333333333333333,
"mega_cap": 0.08333333333333333
},
"headlines": [
{
"title": "Fed officials were split on direction of interest rates at last meeting, minutes show",
"link": "https://news.google.com/rss/articles/CBMia0FVX3lxTE8tZUhVQU4tbmVMVVg1ODA3SENhNTlMancyVDlRQWp4dTN0RFVqczhIUk1lRHJxUHpfUzY1UEg0c2Iyb0loekVSNDU2T3M4b1NIZDZhbVNrTnVhT0g3NE1scms0MHhxbG95OEpJ0gFwQVVfeXFMUGxHQmZYRlNNZGswUTlFYThydFB4eV9DdlkycWtpRXNYb2xvSFpDMG1LbXVFdmMtY1VDWXFXVUpwLWZWWk5aNGE4Z2o1a04xN2FSdTlwTTN0T2JPS1l4Q0tJVHY3czc3ZmxQbWRZa0d0SA?oc=5",
"source": "CNBC",
"published": "2026-07-08",
"age_days": 0,
"query": "FOMC Federal Reserve OR interest rates s",
"category": "monetary_policy"
},
{
"title": "Fed policymakers' inflation concerns grew at June meeting, minutes show",
"link": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNQ0RTaXNnWWRiR3R0S2lvUlNhQVBYcktaZ00wQmxEc25PZldQUkpJdEpUWGlncExsWGR6M2pISWNYQWpxYUtvMDJFaHlrVVZOMHA3Z3cyd1ZWR2RMVjczczZIeGNucll2d3ByUDJqeElKZ3hkUGw2cUdDUXAxSmFrdktTbkJtYVJ2bWpyR1ZoTUM3TlNTM3pyYjhqeGxqYlNGU1ZXRDI2SzU1TlZn?oc=5",
"source": "Reuters",
"published": "2026-07-08",
"age_days": 0,
"query": "FOMC Federal Reserve OR interest rates s",
"category": "monetary_policy"
},
{
"title": "Oil prices little changed as markets weigh impact of US strikes on Iran",
"link": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxOdklGcG9tdzh1UWdoWldFbWpRaXJELXpXclBKYzlJbzBpaXNJMWJBTnRYUFh1WndvTmNVN2x3ZHBlQm94ZVI0M24zdnVHSVZtR0dNVDMxdmM0SmJUTGZLUWZTWGdwcWlQM0JfcHlBVVB6V2lZOEo1bzFHMUZ1ZkM4b2ZCdnFWOGhOZmVkSXVIODdhUWxDYU9mNlMxdnRoRkZBUV9iNEVMakdpZw?oc=5",
"source": "Reuters",
"published": "2026-07-09",
"age_days": 0,
"query": "geopolitical OR tariffs OR oil prices ma",
"category": "commodities"
},
{
"title": "Oil prices rise, and stocks drop worldwide after Trump says ceasefire with Iran is ‘over’",
"link": "https://news.google.com/rss/articles/CBMijAFBVV95cUxQM255ZEIteU82bFZRNFpWYW9fTTlFaXdIajdXbjBYNmEzQTZBNUdXYjNjTGxTRm02S0NUQTBDa2lmYndWOV9sN3JqVFFvemRIaXhXTXFEdlFiVDB3cnc2b09hVF9Pd0dBVWhLMWpsV0UzV0NGQ194SFNVRjZBdGJRbExDN3dyVWROTFJscg?oc=5",
"source": "AP News",
"published": "2026-07-08",
"age_days": 0,
"query": "geopolitical OR tariffs OR oil prices ma",
"category": "commodities"
},
{
"title": "Oil prices surge and markets fall after Trump says Iran ceasefire is over",
"link": "https://news.google.com/rss/articles/CBMixwFBVV95cUxOX2RmNGpLVER2YUdOUEtjVE1QSk0wNXNtcDFzbThsdUliVnA5VmNHbnBsc1hiYkVyV1ByOEtWUTZwdEFQblowa3ptWXV4MXlFdE92eDY3SVVXSjBTNEt1Y01YZ2c1VlR2ZnVwcHdHdVhLcjZHMWQzNUdKS0NzeEVLSFI5WnplUHdReURuSG1xeDlnQmo2cWtDeGRMLU10ZWVRVy0zek5YWGVSVzhTeWxyUzN6Ykg5UkV1cG5DQU00M0tRbEg5endR?oc=5",
"source": "The Washington Post",
"published": "2026-07-08",
"age_days": 0,
"query": "geopolitical OR tariffs OR oil prices ma",
"category": "commodities"
},
{
"title": "Oil prices surge, stocks slide after Trump says Iran ceasefire is ‘over’",
"link": "https://news.google.com/rss/articles/CBMivgFBVV95cUxPcFJGM3EyYnhPN3ZsY2hPcmpBMHlaNExqUXJEb0M0QktaazczNDdWSXJ3TFZMY0xsczBHVzktS0tScnVqbzdBVVdZUDFsRDVkcFhyZWF5U1NiV2JWdmxidlh0WmhabmhLc0FoRWdFdWF4dWVWMTBvcU1zMi1wR05xaGF1TmdmMnZWOGZxbmUxaUtfU2JJVkM1SUhmbUhzR01tVWRDSU9QOGlXSVJ4VzNzZWZPMzJlS1NUMlZfcVd3?oc=5",
"source": "NBC News",
"published": "2026-07-08",
"age_days": 0,
"query": "geopolitical OR tariffs OR oil prices ma",
"category": "commodities"
},
{
"title": "Stock Market Today: Stock Market News And Analysis",
"link": "https://news.google.com/rss/articles/CBMid0FVX3lxTE8zdGl1MmxTM2JJa2pLNlFSWVhuZUd1ekRIeVpDcGVqckVJcloxaWlnRHJ3b0hqb291NXk4dlo0SmRQNlhDaGpubDh6ZWNTUHZiYVhjOVJINUxSYXE0NHRiNVE2OW51R2h4N1daaXRIdzVBR1UxT0g4?oc=5",
"source": "Investor's Business Daily",
"published": "2026-07-08",
"age_days": 0,
"query": "S&P 500 market news this week",
"category": "market"
},
{
"title": "‘It’s over’: Oil markets back on edge after US and Iran shred ceasefire",
"link": "https://news.google.com/rss/articles/CBMigAFBVV95cUxQazkya3V4U3pKdzllREVjWWRNU18xcFEwU1M3MWZFVkVQUDJaNm5pWlJQNjVqV3ZwMmpaZDVhT0xGbmVUNVJCUVUzTWRKVm1kZF9BS2lsU3VGSnh0T0Nfb3hITV9peUpob0pWV0dmVW9GRTdTWko3WEQ5cWZpb0tNNA?oc=5",
"source": "Politico",
"published": "2026-07-08",
"age_days": 0,
"query": "geopolitical OR tariffs OR oil prices ma",
"category": "commodities"
},
{
"title": "Chip Stocks Boost Nasdaq, S&P 500 Futures to Start the Week",
"link": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxOTldUVGxWRElUTFlkeFRIbml1OFhzUHpDWk5TTWFMUmdsOFY0NjJKa2c3aGw2WEkxb1VjenVxc0RpbmlUV0tWamxWOURhdGdaQ0JMdE9lMUhGMG1IMV9TS3F2Y0ZKUGI4RF9Wbzl6TUxVeExjUUxkQkhtTWhINEowcFg2OVpKdUZaX0tIZWppQVAyclYyY0pPY051UVhvemRiUGMtTTlpNEs1TnVXOEZLNUNZazVDdFdGQktF?oc=5",
"source": "Schaeffer's Investment Research",
"published": "2026-07-06",
"age_days": 2,
"query": "S&P 500 market news this week",
"category": "market"
},
{
"title": "S&P 500, Nasdaq close sharply higher as Broadcom rallies",
"link": "https://news.google.com/rss/articles/CBMiswFBVV95cUxOeURVeHcyZ0dZTjVKUU5YT1c0UFpHZjliRDdNamlueUo3M0pyaDFDYkNPYlZnTDMwY1I2Q2ZodmhPeWdKeUZNY2wzRUgxOUowQ0pLMnF0ajJqdnI2dS1uWjdIS1hSLUFkeHN3VnZadWJJYk9XZnAyczBjOVBXcmxCSlNCcVRWZjZnVkZQQWlYam9MQWZ2T0hpWnN0aHRSU2o2MU9WRlB0THYxREJzVkM2U1NSOA?oc=5",
"source": "Reuters",
"published": "2026-07-06",
"age_days": 2,
"query": "S&P 500 market news this week",
"category": "market"
},
{
"title": "S&P 500 Earnings Outlook Hinges On Tech, Energy And The Fed",
"link": "https://news.google.com/rss/articles/CBMirgFBVV95cUxOdWY3dGM5ZzVrRFoxZ0JfMkNZTC1QOFcwVkl6MWhhczJCRFY1R1p3MHZ6V3ljcll5UXRrU3lnRS1NMThBVGVzVzFnOGNzTTBHZkhrTWlDbTNSVmg2RnA3aTBKQnRtRnItSndoNEQ0cUFocHBld2tjWVpicllqTVVOOFN4d1U1YlQtYmVrRnNKWWJvNDFJc2ZVeWw0NjFFZVlod29BSks1SFZ2TVJNRWc?oc=5",
"source": "Forbes",
"published": "2026-07-05",
"age_days": 3,
"query": "S&P 500 market news this week",
"category": "mega_cap"
},
{
"title": "Weekly market commentary",
"link": "https://news.google.com/rss/articles/CBMingFBVV95cUxQLWJDTjBBalYwVHVpc0VxV1BwRE1xeUt1RWlLQ1VJdnJQRXNnb3p6MnFNbjRBV0s0TnlldW4wSVIycFRQeVNISWJ3VV9wMWdjX1ZndE1Tc24tNzc0anNYWjl0SVBsRDhSa0dVTWlyVVYxX0w5b2JhTFB0Tm9Vb2FwYVZubTU1SVJlcy0zMEpXOEM4ZlhiSU1QazdVQVlldw?oc=5",
"source": "BlackRock",
"published": "2026-07-06",
"age_days": 3,
"query": "S&P 500 market news this week",
"category": "market"
}
]
},
"top": [
{
"symbol": "ILMN",
"name": "Illumina Inc. Common Stock",
"sector": "Health Care",
"industry": "Medical Specialities",
"exchange": "NASDAQ",
"market_cap": 28415653000.0,
"dollar_volume": 497776507.06,
"price": 187.80999755859375,
"last_date": "2026-07-08",
"return_1d": -0.020598649673518765,
"return_5d": 0.06813396805313099,
"return_20d": 0.18837006793946198,
"return_60d": 0.5530471932906753,
"return_120d": 0.277705902033782,
"ma20_distance": 0.08533402671358381,
"ma50_distance": 0.19814838144715607,
"ma200_distance": 0.42739283628141367,
"high_52w": 194.3300018310547,
"near_52w_high": 0.9664488024956164,
"volume_ratio": 1.1571623588098172,
"volume_ratio_1d": 1.2348482142441153,
"volatility_20d": 0.41299652850302704,
"drawdown_52w": -0.03355119750438362,
"trend_score": 1.0,
"sector_score": 0.9230769230769231,
"rs_20d": 0.18000983153370154,
"rs_60d": 0.38879433532978114,
"entry_setup_score": 0.8965977845071249,
"overheat_score": 0.0,
"macro_fit": 0.6498194441807176,
"research_score": 65.56610234069103,
"heat_score": 48.9242718446602,
"breakdown": {
"research_quality": 65.56610234069103,
"market_heat": 48.9242718446602,
"macro_event": 9.097472218530045,
"entry_setup": 6.276184491549874,
"overheat_penalty": -0.0,
"near_52w_high": 3.471844660194175,
"news": 10.0,
"relative_strength": 12.928155339805826,
"volume": 7.269902912621359,
"liquidity": 3.320388349514563
},
"score": 56.15623011731281,
"is_near_high": true,
"is_high_volume": false,
"items": [
{
"title": "Illumina (ILMN) Stock May Be 27% Undervalued Following Strong Q1 Results",
"link": "https://finance.yahoo.com/markets/stocks/articles/illumina-ilmn-stock-may-27-231410993.html?.tsrc=rss",
"published": "2026-07-08",
"age_days": 0,
"source": "Yahoo Finance",
"snippet": "Illumina stock has surged over the past year, and the current debate centers on a split valuation picture, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to upside while market multiples paint the stock as expensive. Illumina has returned 92.7% over the past year, which puts extra attention on whether recent gains already reflect the company’s fundamentals. Recent optimism around Illumina’s sequencing platform recovery and expanding clinical use cases can support higher...",
"relevance": 2.0,
"category": "业绩/指引",
"sentiment": "positive",
"freshness": 1.0,
"positive_hits": 2.0,
"negative_hits": 0.0
},
{
"title": "Illumina (ILMN) Jumps On Earnings And Guidance As Valuation Questions Remain",
"link": "https://finance.yahoo.com/markets/stocks/articles/illumina-ilmn-jumps-earnings-guidance-171112645.html?.tsrc=rss",
"published": "2026-07-08",
"age_days": 0,
"source": "Yahoo Finance",
"snippet": "Illumina (ILMN) stock has surged after quarterly results showed $1.09b in revenue, up 4.8% year on year, and full year EPS guidance beat analyst estimates, reinforcing management’s message about ecosystem progress. See our latest analysis for Illumina. At a share price of $191.76, Illumina has seen strong momentum build, with a 7 day share price return of 9.06% and a 90 day share price return of 49.81%. The 1 year total shareholder return of 93.17% contrasts with a 5 year total shareholder...",
"relevance": 2.0,
"category": "分析师/评级",
"sentiment": "positive",
"freshness": 1.0,
"positive_hits": 5.0,
"negative_hits": 0.0
},
{
"title": "Illumina (ILMN) Is Up 9.1% After Raising EPS Outlook On Revenue Beat Has The Bull Case Changed?",
"link": "https://finance.yahoo.com/markets/stocks/articles/illumina-ilmn-9-1-raising-161749887.html?.tsrc=rss",
"published": "2026-07-08",
"age_days": 0,
"source": "Yahoo Finance",
"snippet": "Illumina recently reported past-quarter revenues of US$1.09 billion, a 4.8% year-on-year increase that surpassed analyst expectations, alongside raising its full-year EPS guidance. Management emphasized the strength of Illumina’s sequencing ecosystem and progress on its long-term plan, reinforcing confidence in the company’s positioning despite emerging high-end competition such as Roche’s new Axelios NGS system. With Illumina’s latest results beating revenue forecasts and lifting full-year...",
"relevance": 1.6500000000000001,
"category": "分析师/评级",
"sentiment": "positive",
"freshness": 1.0,
"positive_hits": 2.0,
"negative_hits": 0.0
},
{
"title": "EXEL vs. ILMN: Which Stock Should Value Investors Buy Now?",
"link": "https://finance.yahoo.com/markets/stocks/articles/exel-vs-ilmn-stock-value-154003663.html?.tsrc=rss",
"published": "2026-07-08",
"age_days": 0,
"source": "Yahoo Finance",
"snippet": "EXEL vs. ILMN: Which Stock Is the Better Value Option?",
"relevance": 1.6500000000000001,
"category": "市场观点",
"sentiment": "neutral",
"freshness": 1.0,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "Illumina, Inc. (ILMN) Hit a 52 Week High, Can the Run Continue?",
"link": "https://finance.yahoo.com/markets/stocks/articles/illumina-inc-ilmn-hit-52-131505376.html?.tsrc=rss",
"published": "2026-07-08",
"age_days": 0,
"source": "Yahoo Finance",
"snippet": "Illumina (ILMN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.",
"relevance": 1.6500000000000001,
"category": "市场观点",
"sentiment": "neutral",
"freshness": 1.0,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "Is C4 Therapeutics (CCCC) Stock Outpacing Its Medical Peers This Year?",
"link": "https://www.nasdaq.com/articles/c4-therapeutics-cccc-stock-outpacing-its-medical-peers-year-0",
"published": "2026-07-07",
"age_days": 2,
"source": "Zacks",
"snippet": "Here is how C4 Therapeutics, Inc. (CCCC) and Illumina (ILMN) have performed compared to their sector so far this year.",
"relevance": 1.7,
"category": "监管/法律",
"sentiment": "neutral",
"freshness": 1.0,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "Piper Sandler raises Illumina stock price target on clinical strength",
"link": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxNQ2FDUFpHTkJSWE5QWXprcE4wT2VxcjFjZGJIb08yMFpXNURJWWw5alJXVkZKam93ZE1sd0hESHlDUDY4VjhHaFVELUNZN0lXZXdpVmN3U0ZxLUxVVjNtMWlrb3plM0JKVUNMTXRqMUw3Q2xDNVlvMzBFaVM1dXhFUkRSX1EwdzdJa0RPaEdMVlFzNDlkTVlXTlFWVlVnRVRhemFnRm02NFJaRllBamF1SDkwLUJDVjNrLTFQREowekUyTHBfX09QMA?oc=5",
"published": "2026-07-01",
"age_days": 7,
"source": "Investing.com",
"snippet": "Piper Sandler raises Illumina stock price target on clinical strength Investing.com",
"relevance": 0.7,
"category": "分析师/评级",
"sentiment": "positive",
"freshness": 0.65,
"positive_hits": 1.0,
"negative_hits": 0.0
},
{
"title": "Illumina Stock Is Up 32% in 2026: Has the GRAIL Recovery Already Been Priced In?",
"link": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNWlpjN2RyeExiOHl1aDNkaUhZeHpvQXFPNWRJX1Y2Ukd3eVUwdTBUWExXcWhaR1dCMnBYSXhNem51bVl3dHUzazllU3VHU0ljYVZ5V2RfamNHMTF3dWN6N1NDNGYtOG45RkwwUTdldUd3STY3SThEWVE2SmZPREZtdGF6Wi1seThacXdnNHNJN3dsZWdJcnhocm1XTFN6MlA4UEpjUVFB?oc=5",
"published": "2026-06-26",
"age_days": 12,
"source": "TIKR.com",
"snippet": "Illumina Stock Is Up 32% in 2026: Has the GRAIL Recovery Already Been Priced In? TIKR.com",
"relevance": 0.7,
"category": "市场观点",
"sentiment": "neutral",
"freshness": 0.3,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "Illumina (ILMN) Stock After 80% One-Year Rebound Is The Price Now Justified",
"link": "https://news.google.com/rss/articles/CBMilgFBVV95cUxPbEM5TV9ld2cxRjhFOWxwcVBWbXZYU3NjaFBtak8zUEl2ck40dHhrU3ptV1h0OHlVZXE4TjQ2Z20waC1jN1ZyQ0t1Rl9DWVFzTVQwa0lrcDZDREtWUFFuV3M2dnFGOGdHSDRrUW1LSXJPaDNDcVdwLS03aFMzeEVoZ0REanFMMGNraGJiLXFJa291dll2bEE?oc=5",
"published": "2026-06-24",
"age_days": 15,
"source": "Yahoo Finance",
"snippet": "Illumina (ILMN) Stock After 80% One-Year Rebound Is The Price Now Justified Yahoo Finance",
"relevance": 2.0,
"category": "市场观点",
"sentiment": "neutral",
"freshness": 0.3,
"positive_hits": 0.0,
"negative_hits": 0.0
}
],
"news_score": 1.0,
"positive_hits": 9.65,
"negative_hits": 0.0,
"news_sources": [
"Investing.com",
"TIKR.com",
"Yahoo Finance",
"Zacks"
],
"catalysts": [
"业绩/指引",
"分析师/评级",
"市场观点"
],
"news_errors": []
},
{
"symbol": "CAH",
"name": "Cardinal Health Inc. Common Stock",
"sector": "Health Care",
"industry": "Other Pharmaceuticals",
"exchange": "NYSE",
"market_cap": 55541918513.0,
"dollar_volume": 638787714.3000001,
"price": 237.14999389648438,
"last_date": "2026-07-08",
"return_1d": -0.0106796243197248,
"return_5d": -0.0017258952109908687,
"return_20d": 0.15977112114417635,
"return_60d": 0.10036186523399815,
"return_120d": 0.1387208304603127,
"ma20_distance": 0.03146812061912918,
"ma50_distance": 0.13057884819791354,
"ma200_distance": 0.1718011400523003,
"high_52w": 239.7100067138672,
"near_52w_high": 0.9893203756802752,
"volume_ratio": 0.9947089947089947,
"volume_ratio_1d": 1.1337988744512213,
"volatility_20d": 0.21606208551802078,
"drawdown_52w": -0.0106796243197248,
"trend_score": 1.0,
"sector_score": 0.9230769230769231,
"rs_20d": 0.1514108847384159,
"rs_60d": -0.06389099272689602,
"entry_setup_score": 1.0,
"overheat_score": 0.0,
"macro_fit": 0.7179801784805563,
"research_score": 63.942345033607175,
"heat_score": 46.56310679611651,
"breakdown": {
"research_quality": 63.942345033607175,
"market_heat": 46.56310679611651,
"macro_event": 10.051722498727788,
"entry_setup": 7.0,
"overheat_penalty": -0.0,
"near_52w_high": 3.8368932038834953,
"news": 10.0,
"relative_strength": 10.310679611650485,
"volume": 5.6854368932038835,
"liquidity": 3.9495145631067956
},
"score": 55.71815240356696,
"is_near_high": true,
"is_high_volume": false,
"items": [
{
"title": "Cardinal Health (CAH) Declines More Than Market: Some Information for Investors",
"link": "https://finance.yahoo.com/markets/stocks/articles/cardinal-health-cah-declines-more-221503628.html?.tsrc=rss",
"published": "2026-07-08",
"age_days": 0,
"source": "Yahoo Finance",
"snippet": "Cardinal Health (CAH) concluded the recent trading session at $237.15, signifying a -1.07% move from its prior day's close.",
"relevance": 2.0,
"category": "市场观点",
"sentiment": "neutral",
"freshness": 1.0,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "McKesson Stock Is Shrinking, And That's The Point",
"link": "https://www.trefis.com/articles/606181/mckesson-stock-is-shrinking-and-thats-the-point/2026-07-08?.tsrc=rss",
"published": "2026-07-08",
"age_days": 0,
"source": "Yahoo Finance",
"snippet": "While the market debates the future of drug pricing, this healthcare giant is steadily handing a larger piece of the business back to its owners.",
"relevance": 1.0,
"category": "医药/审批",
"sentiment": "neutral",
"freshness": 1.0,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "Does Index Removal Amid Solid Results Change The Bull Case For Cardinal Health (CAH)?",
"link": "https://finance.yahoo.com/markets/stocks/articles/does-index-removal-amid-solid-211743255.html?.tsrc=rss",
"published": "2026-07-07",
"age_days": 1,
"source": "Yahoo Finance",
"snippet": "In late June 2026, Cardinal Health, Inc. was removed from the Russell 1000 Defensive, Russell 1000 Growth-Defensive, and Russell 1000 Value-Defensive indices, even as it reported quarterly revenue of US$60.94 billion and net profit of US$399 million. At the same time, upbeat commentary from Jim Cramer and reaffirmed positive analyst views highlighted Cardinal Health’s reputation as a healthcare sector stalwart despite its index reclassifications. Next, we’ll examine how this combination of...",
"relevance": 2.0,
"category": "分析师/评级",
"sentiment": "positive",
"freshness": 1.0,
"positive_hits": 3.0,
"negative_hits": 0.0
},
{
"title": "Cardinal Health stock hits all-time high at 241.86 USD",
"link": "https://news.google.com/rss/articles/CBMirgFBVV95cUxQTEpBM1czODVBMEUxZVJsakNPMzc3TVlqRzVvRXFMR1c1ZlVVY0R1aTFZeHEwT1lFd09JX0EycmRuUWw1U3NWWGt4b0dvblk0QS1CWXlXMVZsRFFCbVhteHVVczNXLUNQb2xVbGQzeWZVcHJYM1Q0bUFFNC1CQ3YxdEJCdnAzVXZBVWxHS1d5aE82eEVucW9SajhBZkt5bWp2UGlpcjNGSXNZM2k5bnc?oc=5",
"published": "2026-07-06",
"age_days": 2,
"source": "Investing.com",
"snippet": "Cardinal Health stock hits all-time high at 241.86 USD Investing.com",
"relevance": 1.0,
"category": "市场观点",
"sentiment": "neutral",
"freshness": 1.0,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "Jim Cramer on Cardinal Health: “It’s Been a Real Stalwart, and I Don’t Think It’s Done”",
"link": "https://finance.yahoo.com/markets/stocks/articles/jim-cramer-cardinal-health-real-142048565.html?.tsrc=rss",
"published": "2026-07-04",
"age_days": 4,
"source": "Yahoo Finance",
"snippet": "Cardinal Health, Inc. (NYSE:CAH) was among the stocks Jim Cramer commented on as he advised investors on how to take advantage of Wednesday’s market rotation. Cramer said that the stock deserves to “trade higher,” as he commented: Can I call your attention to what may be the best one in this group? I’m talking about […]",
"relevance": 2.3,
"category": "市场观点",
"sentiment": "neutral",
"freshness": 0.65,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "Is Cardinal Health (CAH) Fully Valued After Its Russell Index Removal?",
"link": "https://news.google.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?oc=5",
"published": "2026-07-04",
"age_days": 5,
"source": "simplywall.st",
"snippet": "Is Cardinal Health (CAH) Fully Valued After Its Russell Index Removal? simplywall.st",
"relevance": 1.7,
"category": "市场观点",
"sentiment": "neutral",
"freshness": 0.65,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "Cardinal Health: Why This Essential Healthcare Distributor Deserves A Buy Rating",
"link": "https://news.google.com/rss/articles/CBMivAFBVV95cUxNWWxFaDZJeXVrdWt1bGgtbTVoelNDUXNUX1RBLXluM3VVajFvaHl0WWlEMV9WR1JVRVA2RGJOaGNNLUotS1BfTmk0X3ludWVjbnNqU1M0ZXI0RFA1Q0lDUXR4cGNFb2oyYklhQmdCeWJNZlN2aFY0OFc3eGpadE1GdWxGby16OFVpZ004QXRXTGtwMkJwMXNJRVhVZS0zelgxVUp5TURVRW1JdXc3ZHpEYUtEb3lsakxmVVREQQ?oc=5",
"published": "2026-07-03",
"age_days": 5,
"source": "Seeking Alpha",
"snippet": "Cardinal Health: Why This Essential Healthcare Distributor Deserves A Buy Rating Seeking Alpha",
"relevance": 0.7,
"category": "分析师/评级",
"sentiment": "positive",
"freshness": 0.65,
"positive_hits": 1.0,
"negative_hits": 0.0
},
{
"title": "Cardinal Health, Inc. Stock 12‑Month Price Target Raised to $248.27, Implies 4% Upside",
"link": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNTllPZXZVYWdvRnQtUHVoNnBmQXZ5dDRRWDNEZEtJalAwVVhqcTB3ZVY1Z3kxbGhLT0M4SFVHblRTU1c4RXk0YkNrWG1oNDl2d2k5WkEwWi11UHMyRGZ0d005Rzk5eGNIU00taXVyTWdzR0MxQTQ2TXU3TDBuSE96Z2lCZ0F1TktmMDY1c2F0QnFtXy1VZy1KRndvUWFaWFFuNE5Hc29tdmlLcEpack5LcWNxTGtBc2NYSDJRejFDdlVteFhEVVZ4V0lYRDFwQldlYXUwYXFkM0xqVTA?oc=5",
"published": "2026-07-02",
"age_days": 6,
"source": "TradingView",
"snippet": "Cardinal Health, Inc. Stock 12‑Month Price Target Raised to $248.27, Implies 4% Upside TradingView",
"relevance": 1.0,
"category": "分析师/评级",
"sentiment": "positive",
"freshness": 0.65,
"positive_hits": 1.0,
"negative_hits": 0.0
},
{
"title": "Are Investors Undervaluing Cardinal Health (CAH) Right Now?",
"link": "https://finance.yahoo.com/markets/stocks/articles/investors-undervaluing-cardinal-health-cah-134003677.html?.tsrc=rss",
"published": "2026-07-01",
"age_days": 7,
"source": "Yahoo Finance",
"snippet": "Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.",
"relevance": 2.3,
"category": "业绩/指引",
"sentiment": "positive",
"freshness": 0.65,
"positive_hits": 2.0,
"negative_hits": 0.0
}
],
"news_score": 1.0,
"positive_hits": 5.6,
"negative_hits": 0.0,
"news_sources": [
"Investing.com",
"Seeking Alpha",
"TradingView",
"Yahoo Finance",
"simplywall.st"
],
"catalysts": [
"分析师/评级",
"医药/审批",
"市场观点"
],
"news_errors": []
},
{
"symbol": "ANET",
"name": "Arista Networks Inc. Common Stock",
"sector": "Telecommunications",
"industry": "Computer Communications Equipment",
"exchange": "NYSE",
"market_cap": 227978629463.0,
"dollar_volume": 2151964464.15,
"price": 181.0500030517578,
"last_date": "2026-07-08",
"return_1d": 0.08764865883352857,
"return_5d": 0.06575228306975056,
"return_20d": 0.1576087603404155,
"return_60d": 0.2287071296391221,
"return_120d": 0.3934427249875867,
"ma20_distance": 0.0978749127111529,
"ma50_distance": 0.1339125574338329,
"ma200_distance": 0.26110126828222024,
"high_52w": 181.0500030517578,
"near_52w_high": 1.0,
"volume_ratio": 1.1002962931416047,
"volume_ratio_1d": 1.3558263125953482,
"volatility_20d": 0.6582373127079288,
"drawdown_52w": 0.0,
"trend_score": 1.0,
"sector_score": 0.07692307692307693,
"rs_20d": 0.14924852393465504,
"rs_60d": 0.06445427167822793,
"entry_setup_score": 1.0,
"overheat_score": 0.016474625415857647,
"macro_fit": 0.5975288061876214,
"research_score": 60.74721718636694,
"heat_score": 56.00976919577023,
"breakdown": {
"research_quality": 60.74721718636694,
"market_heat": 56.00976919577023,
"macro_event": 8.3654032866267,
"entry_setup": 7.0,
"overheat_penalty": -0.13179700332686117,
"near_52w_high": 3.9378640776699028,
"news": 10.0,
"relative_strength": 11.700970873786407,
"volume": 6.772815533980583,
"liquidity": 5.533980582524272
},
"score": 55.16353862347657,
"is_near_high": true,
"is_high_volume": false,
"items": [
{
"title": "Why Did PENG, ANET, BCRX Shares Surge To 52-Week Highs?",
"link": "https://stocktwits.com/news-articles/markets/equity/why-did-peng-anet-bcrx-shares-surge-to-52-week-highs/cZmokfgR7VS?.tsrc=rss",
"published": "2026-07-09",
"age_days": 0,
"source": "Yahoo Finance",
"snippet": "Penguin Solutions, Arista Networks, and Biocryst Pharmaceuticals surged to 52-week highs on Wednesday amid a rotation into technology and healthcare stocks.",
"relevance": 2.3,
"category": "市场观点",
"sentiment": "positive",
"freshness": 1.0,
"positive_hits": 1.0,
"negative_hits": 0.0
},
{
"title": "Notable Wednesday Option Activity: ANET, BZH, SOC",
"link": "https://www.nasdaq.com/articles/notable-wednesday-option-activity-anet-bzh-soc",
"published": "2026-07-08",
"age_days": 1,
"source": "BNK Invest",
"snippet": "Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Arista Networks Inc (Symbol: ANET), where a total volume of 45,023 contracts has been traded thus far today, a contract volume which is representative of approxi",
"relevance": 1.7,
"category": "产品/订单",
"sentiment": "positive",
"freshness": 1.0,
"positive_hits": 1.0,
"negative_hits": 0.0
},
{
"title": "ANET Stock Quote Price and Forecast",
"link": "https://news.google.com/rss/articles/CBMiUEFVX3lxTE9BbWlkeUcySkdqVVBlWGZMWU1TenVYc0lmT2ExN0IzUkVxamxKZUg3MFB4a2hNZV9GQ0RsbmpLeFZqaFZRVWY0dUVvNndVYWJh?oc=5",
"published": "2026-07-06",
"age_days": 3,
"source": "CNN",
"snippet": "ANET Stock Quote Price and Forecast CNN",
"relevance": 1.35,
"category": "市场观点",
"sentiment": "neutral",
"freshness": 1.0,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "The AI Supercycle Needs More Than Just Chips. This Growth Stock Builds the Network That Connects Them.",
"link": "https://www.nasdaq.com/articles/ai-supercycle-needs-more-just-chips-growth-stock-builds-network-connects-them",
"published": "2026-07-05",
"age_days": 4,
"source": "The Motley Fool",
"snippet": "Key PointsArista sells networking switching hardware and software to leading AI companies.",
"relevance": 0.7,
"category": "市场观点",
"sentiment": "positive",
"freshness": 0.65,
"positive_hits": 1.0,
"negative_hits": 0.0
},
{
"title": "ANET Rises 56% in a Year: Should Investors Buy, Sell or Hold?",
"link": "https://www.nasdaq.com/articles/anet-rises-56-year-should-investors-buy-sell-or-hold",
"published": "2026-07-03",
"age_days": 6,
"source": "Zacks",
"snippet": "Arista has surged 56% in a year as AI networking demand drives growth, but can strong momentum outweigh customer concentration, competition and higher R&D?",
"relevance": 1.35,
"category": "产品/订单",
"sentiment": "positive",
"freshness": 0.65,
"positive_hits": 3.0,
"negative_hits": 0.0
},
{
"title": "Where Arista Networks Stock Is Most Exposed",
"link": "https://news.google.com/rss/articles/CBMipwFBVV95cUxNRERGRktPdmJ2TWItZ3BSWlRxclNseWlOTHItUzNpb05YOEJ6WkdHZ1lHSVJzcVgwb3llTTN2dlNMbi1XTm0zUEJVbXpSVGlTUjBWSDUxcWRwMlFHcE4zd2RtUVVxSzFQNEdwRWFaQVZMWFVLNmkyaGd6QkVhZXdDSHpER0l3MktXNGVJRmJvT2Z0enNOS2FDUUtxZXRxcDluV3lCUkppVQ?oc=5",
"published": "2026-06-30",
"age_days": 9,
"source": "Trefis",
"snippet": "Where Arista Networks Stock Is Most Exposed Trefis",
"relevance": 1.0,
"category": "市场观点",
"sentiment": "neutral",
"freshness": 0.65,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "Arista Networks Stock Is Up 55% Over the Past Year. Here’s What Investors Should Know",
"link": "https://news.google.com/rss/articles/CBMirAFBVV95cUxOTTI4NWdORzFWZ0VsbnZpa09XSVE1R3EtQVdJMDNHVmZvanlEUHJsQjdYdkx4ZzY0ZkUxUmQxUVp1ZXFWT1E3d19nMzdtNFpDbDBFNFB6MmFCZDNPNi1LTURqWGRpVnMwTHRFaHRZSFAxd1lsQkx5c2sxd1MxU0M4T3NUX2c4U245dW1hNW9HQUZINXl1eko1bC1tSVd1T1FBdGpFejhRQS1UVXow?oc=5",
"published": "2026-06-27",
"age_days": 12,
"source": "TIKR.com",
"snippet": "Arista Networks Stock Is Up 55% Over the Past Year. Here’s What Investors Should Know TIKR.com",
"relevance": 1.0,
"category": "市场观点",
"sentiment": "neutral",
"freshness": 0.3,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "KeyBanc Raises PT on Arista Networks (ANET) Stock",
"link": "https://news.google.com/rss/articles/CBMinwFBVV95cUxQUzd6MmVzcmNyWW1KN3N0a0tfQVdTMlZJNUF1dUZuSk5sV3BLTXJzQnFfdDFnYUtUb2d3dkVpaEhUdk94Yl9zLVdqV1ZHZnNRWFE4QzVOY3RuSmJrZzhvVy1pakJvVVRwdWltUFRmSlpUaUpsdlNfWndaQmF0RGpPT01FR19PLW1UVWlmVWw2LVBxbWFocjRMZm9HSDBYeFk?oc=5",
"published": "2026-06-25",
"age_days": 14,
"source": "Yahoo Finance",
"snippet": "KeyBanc Raises PT on Arista Networks (ANET) Stock Yahoo Finance",
"relevance": 2.3,
"category": "市场观点",
"sentiment": "positive",
"freshness": 0.3,
"positive_hits": 1.0,
"negative_hits": 0.0
},
{
"title": "Arista Networks’ Andreas Bechtolsheim sells $43 million in ANET stock",
"link": "https://news.google.com/rss/articles/CBMizAFBVV95cUxNaVdmY1d3RThWN1VXUE9id2o4LWJTY01MMy1VTGFFNzJ1TEFYMGI4dExvTXpzWEp6SzQ4QTk4ZkR2OGJGRHMwdElUS1lsYkZ3cHRBWmNpN3I1cHZ0ZmI4bDZhRzRPblE1TlhNU0xvWVhXV1BfWnd2bjdNaGJNNkJMYy1qanhHNW04R3lPSkEzMEJVVWVUUzRMLUdNLTZWMC1EdjJiUzVtSmNZOUloaEltc01mM21kOGdpYUhYMXdEWHFYOU1wRVBiQjFZMW4?oc=5",
"published": "2026-06-22",
"age_days": 17,
"source": "Investing.com",
"snippet": "Arista Networks’ Andreas Bechtolsheim sells $43 million in ANET stock Investing.com",
"relevance": 2.0,
"category": "市场观点",
"sentiment": "neutral",
"freshness": 0.3,
"positive_hits": 0.0,
"negative_hits": 0.0
}
],
"news_score": 1.0,
"positive_hits": 4.8999999999999995,
"negative_hits": 0.0,
"news_sources": [
"BNK Invest",
"CNN",
"Investing.com",
"TIKR.com",
"The Motley Fool",
"Trefis",
"Yahoo Finance",
"Zacks"
],
"catalysts": [
"产品/订单",
"市场观点"
],
"news_errors": []
},
{
"symbol": "ABBV",
"name": "AbbVie Inc. Common Stock",
"sector": "Health Care",
"industry": "Biotechnology: Pharmaceutical Preparations",
"exchange": "NYSE",
"market_cap": 446539217580.0,
"dollar_volume": 1736005094.8600001,
"price": 252.74000549316406,
"last_date": "2026-07-08",
"return_1d": -0.007500445509913245,
"return_5d": 0.004371348379366147,
"return_20d": 0.1330075635216248,
"return_60d": 0.2154467756360714,
"return_120d": 0.14491508717175106,
"ma20_distance": 0.06170306159793326,
"ma50_distance": 0.13918587142113292,
"ma200_distance": 0.13577308104980834,
"high_52w": 261.07000732421875,
"near_52w_high": 0.9680928425427675,
"volume_ratio": 0.9514015742972153,
"volume_ratio_1d": 0.9363983430791594,
"volatility_20d": 0.36123994534792503,
"drawdown_52w": -0.03190715745723249,
"trend_score": 0.8,
"sector_score": 0.9230769230769231,
"rs_20d": 0.12464732711586435,
"rs_60d": 0.051193917675177225,
"entry_setup_score": 1.0,
"overheat_score": 0.0,
"macro_fit": 0.6686400198734819,
"research_score": 63.14916542195668,
"heat_score": 45.654368932038835,
"breakdown": {
"research_quality": 63.14916542195668,
"market_heat": 45.654368932038835,
"macro_event": 9.360960278228745,
"entry_setup": 7.0,
"overheat_penalty": -0.0,
"near_52w_high": 3.5184466019417475,
"news": 9.7175,
"relative_strength": 11.359223300970875,
"volume": 5.110679611650485,
"liquidity": 5.359223300970874
},
"score": 54.30496638820247,
"is_near_high": true,
"is_high_volume": false,
"items": [
{
"title": "SLS Stock Snaps 2-Day Slide: Sellas’ SLS009 AML Trial Spotlights Big Pharma Drug Combo From ABBV, RHHBY And BMY",
"link": "https://stocktwits.com/news-articles/markets/equity/sls-aml-trial-big-pharma-abbv-rhhby-bmy-drug-combo/cZmomx9R7Vl?.tsrc=rss",
"published": "2026-07-09",
"age_days": 0,
"source": "Yahoo Finance",
"snippet": "SLS009 traces back to Sellas’ 2022 GenFleet licensing deal, when the company obtained rights outside Greater China to GFH009, now known as SLS009.",
"relevance": 1.6500000000000001,
"category": "产品/订单",
"sentiment": "neutral",
"freshness": 1.0,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "AbbVie Earnings Preview: What to Expect",
"link": "https://www.barchart.com/story/news/3180668/abbvie-earnings-preview-what-to-expect?.tsrc=rss",
"published": "2026-07-08",
"age_days": 0,
"source": "Yahoo Finance",
"snippet": "AbbVie will release its second-quarter earnings later this month, and analysts anticipate a double-digit bottom-line growth.",
"relevance": 1.6500000000000001,
"category": "分析师/评级",
"sentiment": "positive",
"freshness": 1.0,
"positive_hits": 1.0,
"negative_hits": 0.0
},
{
"title": "3 High-Yield Dividend Stocks to Buy and Hold Forever (Hint: AbbVie Makes the List)",
"link": "https://www.nasdaq.com/articles/3-high-yield-dividend-stocks-buy-and-hold-forever-hint-abbvie-makes-list",
"published": "2026-07-07",
"age_days": 2,
"source": "The Motley Fool",
"snippet": "Key PointsAbbVie is hitting its stride now that it has transitioned past Humira's patent expiration.",
"relevance": 1.7,
"category": "并购/资本",
"sentiment": "neutral",
"freshness": 1.0,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "EU Approves Expanded Use of ABBV's Tepkinly in Follicular Lymphoma",
"link": "https://www.nasdaq.com/articles/eu-approves-expanded-use-abbvs-tepkinly-follicular-lymphoma",
"published": "2026-07-07",
"age_days": 2,
"source": "Zacks",
"snippet": "AbbVie's EU approval expands Tepkinly into a first-of-its-kind bispecific lymphoma combination, backed by phase III data showing strong efficacy.",
"relevance": 1.35,
"category": "医药/审批",
"sentiment": "positive",
"freshness": 1.0,
"positive_hits": 2.0,
"negative_hits": 0.0
},
{
"title": "Stronger Bet Than AbbVie Stock: INCY Delivers More",
"link": "https://news.google.com/rss/articles/CBMirwFBVV95cUxONm51b0YxOXJyV3UwcFV5WEx1aHJwM1pJeUZnSzdQbmlGOXJpaVFFX1M5c0RBSEdaZ0ptVWVZYjZ4bEFBS0ZvLUJYekJEbGF1a3hkZ0ZqSkJFM1Q5ZkhqbjVldHVFZVpWSTVETjRJaWhMV2ZYbC12OVo1ME15VTZJZjNaZ2l0LWp5RHhHbllZMnh2aHpxMVFzckdheGJ6VzlBMWJBNzhINjY5LW5jYm5V?oc=5",
"published": "2026-07-02",
"age_days": 7,
"source": "Trefis",
"snippet": "Stronger Bet Than AbbVie Stock: INCY Delivers More Trefis",
"relevance": 1.7,
"category": "市场观点",
"sentiment": "positive",
"freshness": 0.65,
"positive_hits": 1.0,
"negative_hits": 0.0
},
{
"title": "AbbVie Stock Rockets 17% With 5-Day Winning Streak",
"link": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNOHF5YWY1ZWJOanJMZWY3bjFxTmN2dkdkTC1wSUJSZ3BHVHcyLXJCZFF2QWNOVWxNSVg3SHdaa1YyUlhXQ1QtWWFTTkVJS1RwTTYxamk1cHlWZHRuTEhjNlpya2c4T0NLVlpTSFpBZmJtaFlkaFl6XzlIVWF2ZzBjQU0wSFNGdHVQQUZXX1Nhck1IRUNn?oc=5",
"published": "2026-06-29",
"age_days": 10,
"source": "Yahoo Finance",
"snippet": "AbbVie Stock Rockets 17% With 5-Day Winning Streak Yahoo Finance",
"relevance": 2.0,
"category": "市场观点",
"sentiment": "neutral",
"freshness": 0.65,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "AbbVie vs. Pfizer: Which Pharma Giant Stock Is a Better Buy in 2026?",
"link": "https://news.google.com/rss/articles/CBMiugFBVV95cUxQRGRLc1ZXM2FBLTROUUlMQ0NWMWY1c0U4SlI5YnVKMmdETVJkQXROM3JxaUl4TTRvRlFsUUZMc29QTWY2akZJX0t5ZG5XZW9FQVQ2S3VCa2oyWUUxTlhEdm5VWVlqMnVNdHlIM2h2RzVIZUJMWTNPUXg4Q3EyeUk2Zk1aeFVZNUJ3Uko4QklLZTcxMF9hSTVFZ0hneDRCM29zV2ZJRjhxZ0RIbkF4VnBHdEdRUVMxdEs2N0E?oc=5",
"published": "2026-06-25",
"age_days": 14,
"source": "The Motley Fool",
"snippet": "AbbVie vs. Pfizer: Which Pharma Giant Stock Is a Better Buy in 2026? The Motley Fool",
"relevance": 1.7,
"category": "市场观点",
"sentiment": "neutral",
"freshness": 0.3,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "Why AbbVie Is Spending $11 Billion to Buy Apogee Therapeutics—and Why the Stock Is Rising",
"link": "https://news.google.com/rss/articles/CBMiggFBVV95cUxPc0tVT0o5Q0piVzBQakZ0QkZXOXJPbjBRNGg3SUt4NHZUeXh6QU1vQzRpdWRTMTllM0h4NDFWTS1rMGNrU1NhSV9RVFNxdnVUZHQyV2FSMzU4bVlXS0RxRUowd3NSQjdaTGJnaURZR0VOdWwxMWRjRWRsYm12R0FOZmdn?oc=5",
"published": "2026-06-22",
"age_days": 17,
"source": "Barron's",
"snippet": "Why AbbVie Is Spending $11 Billion to Buy Apogee Therapeutics—and Why the Stock Is Rising Barron's",
"relevance": 1.7,
"category": "市场观点",
"sentiment": "neutral",
"freshness": 0.3,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "AbbVie Goes On The Offensive With $10.9 Billion Takeover",
"link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxNM01TYno1alhZU0J0bTF6NEdGdTlpY0ltTVdMekluZ3ZGdWZncHRmT2NlY2hZS3NiZUVIM0w2bmJQUUZyQ0E0RFFVdE4tODg0QjlIM1VtVnVTMXJPRlhfTnFKM19FclJzb2lVaG84WE5IRFAzaFRLUTVTbFlXRUVWWl9lUnFzSFduVGdvRUk3OUc3aDBzZFBuTXln?oc=5",
"published": "2026-06-22",
"age_days": 17,
"source": "Investor's Business Daily",
"snippet": "AbbVie Goes On The Offensive With $10.9 Billion Takeover Investor's Business Daily",
"relevance": 1.35,
"category": "市场观点",
"sentiment": "neutral",
"freshness": 0.3,
"positive_hits": 0.0,
"negative_hits": 0.0
}
],
"news_score": 0.97175,
"positive_hits": 3.65,
"negative_hits": 0.0,
"news_sources": [
"Barron's",
"Investor's Business Daily",
"The Motley Fool",
"Trefis",
"Yahoo Finance",
"Zacks"
],
"catalysts": [
"产品/订单",
"分析师/评级",
"医药/审批",
"市场观点",
"并购/资本"
],
"news_errors": []
},
{
"symbol": "VRTX",
"name": "Vertex Pharmaceuticals Incorporated Common Stock",
"sector": "Health Care",
"industry": "Biotechnology: Pharmaceutical Preparations",
"exchange": "NASDAQ",
"market_cap": 126504233995.0,
"dollar_volume": 1139930842.49,
"price": 498.42999267578125,
"last_date": "2026-07-08",
"return_1d": -0.04561035389989232,
"return_5d": 0.0034223454429047617,
"return_20d": 0.125225759189876,
"return_60d": 0.142480585938634,
"return_120d": 0.09624558021353247,
"ma20_distance": 0.04489046350164094,
"ma50_distance": 0.10306336659726512,
"ma200_distance": 0.11805076309844131,
"high_52w": 529.5900268554688,
"near_52w_high": 0.9411619694488857,
"volume_ratio": 1.0644028368365797,
"volume_ratio_1d": 1.295496257581136,
"volatility_20d": 0.338773326702861,
"drawdown_52w": -0.05883803055111425,
"trend_score": 1.0,
"sector_score": 0.9230769230769231,
"rs_20d": 0.11686552278411555,
"rs_60d": -0.021772272022260175,
"entry_setup_score": 1.0,
"overheat_score": 0.0,
"macro_fit": 0.676809699380778,
"research_score": 63.634675130694546,
"heat_score": 44.2873786407767,
"breakdown": {
"research_quality": 63.634675130694546,
"market_heat": 44.2873786407767,
"macro_event": 9.475335791330892,
"entry_setup": 7.0,
"overheat_penalty": -0.0,
"near_52w_high": 3.1844660194174756,
"news": 9.77,
"relative_strength": 10.660194174757281,
"volume": 6.462135922330097,
"liquidity": 4.9864077669902915
},
"score": 54.25372702543038,
"is_near_high": true,
"is_high_volume": false,
"items": [
{
"title": "Vertex (VRTX) Stock May Be 36% Undervalued Following Its $10b Deal",
"link": "https://finance.yahoo.com/markets/stocks/articles/vertex-vrtx-stock-may-36-131211956.html?.tsrc=rss",
"published": "2026-07-08",
"age_days": 0,
"source": "Yahoo Finance",
"snippet": "Vertex Pharmaceuticals stock has delivered a strong 163.3% return over the past 5 years, and the latest Discounted Cash Flow (DCF) intrinsic value estimate now points to meaningful upside relative to the current share price, even though market based valuation checks look more balanced. Over 5 years, a 163.3% total return suggests investors have already priced in a lot of success for Vertex Pharmaceuticals, which raises the bar for any further potential upside. The planned US$10b acquisition...",
"relevance": 2.0,
"category": "产品/订单",
"sentiment": "positive",
"freshness": 1.0,
"positive_hits": 2.0,
"negative_hits": 0.0
},
{
"title": "Collect 9.0% On VRTX Stock Now, And Still Keep 15% Of Upside",
"link": "https://www.trefis.com/articles/605945/collect-9-0-on-vrtx-stock-now-and-still-keep-15-of-upside/2026-07-08?.tsrc=rss",
"published": "2026-07-08",
"age_days": 0,
"source": "Yahoo Finance",
"snippet": "Get paid a guaranteed income on your Vertex shares today, which you keep no matter what, for agreeing to sell them at a higher price if the stock keeps climbing.",
"relevance": 1.6500000000000001,
"category": "业绩/指引",
"sentiment": "neutral",
"freshness": 1.0,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "VRTX Stock Quote Price and Forecast",
"link": "https://news.google.com/rss/articles/CBMiUEFVX3lxTE9GcERsNGUxVnJ5ODZ2TGpoZGlDMnJtMmVZWkNBSmktQlphWThBZXpyTGtmNVQzZ2xkQUs0SWxTSzlVN2x1R3VzYlRhU2xZOXRT?oc=5",
"published": "2026-07-08",
"age_days": 1,
"source": "CNN",
"snippet": "VRTX Stock Quote Price and Forecast CNN",
"relevance": 1.0,
"category": "市场观点",
"sentiment": "neutral",
"freshness": 1.0,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "Crinetics Pharma Soars After Vertex Pharma Agrees To $10 Bln Acquisition Deal",
"link": "https://www.nasdaq.com/articles/crinetics-pharma-soars-after-vertex-pharma-agrees-10-bln-acquisition-deal",
"published": "2026-07-07",
"age_days": 2,
"source": "RTTNews",
"snippet": "(RTTNews) - Vertex Pharmaceuticals Incorporated (VRTX) and Crinetics Pharmaceuticals, Inc. (CRNX) announced an agreement under which Vertex will acquire Crinetics for $85.00 per share in cash, for a total equity value of approximately $10 billion, or approximately $8.8 billion ne",
"relevance": 2.0,
"category": "产品/订单",
"sentiment": "neutral",
"freshness": 1.0,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "VRTX to Strengthen Rare Disease Portfolio With $10B Crinetics Buyout",
"link": "https://www.nasdaq.com/articles/vrtx-strengthen-rare-disease-portfolio-10b-crinetics-buyout",
"published": "2026-07-07",
"age_days": 2,
"source": "Zacks",
"snippet": "Vertex to acquire CRNX for $10B, adding approved rare disease drug Palsonify and late-stage pipeline assets to expand its endocrinology portfolio.",
"relevance": 1.35,
"category": "医药/审批",
"sentiment": "positive",
"freshness": 1.0,
"positive_hits": 1.0,
"negative_hits": 0.0
},
{
"title": "Vertex To Acquire Crinetics Pharma For $10 Bln",
"link": "https://www.nasdaq.com/articles/vertex-acquire-crinetics-pharma-10-bln",
"published": "2026-07-06",
"age_days": 3,
"source": "RTTNews",
"snippet": "(RTTNews) - Vertex Pharmaceuticals (VRTX) said Monday it has agreed to acquire Crinetics Pharmaceuticals (CRNX) in an all-cash deal valued at approximately $10 billion, strengthening its portfolio with commercial and late-stage endocrinology assets.",
"relevance": 1.7,
"category": "产品/订单",
"sentiment": "neutral",
"freshness": 1.0,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "VRTX rises after CASGEVY label expansion broadens patient reach",
"link": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOVkE1YmZkSEQ5QnU3b0NWVXlOY1lpOVZIRmtDT2I1bGpZZGM2cEtWMk4wX3ZDTi1lYzdFS3Z6b0I4UkR1dkVhZmxIaGtQeE9JZUJhQ1k1eTZabG5DWnFCbGRkU1c1Y0Y3VVRCbXVacHB1TlQxYXdJNkRKWEFtVXpBcExsZDZ3LXcwV0I5TlM3bG03eDBXdERfaHdGOGM?oc=5",
"published": "2026-07-02",
"age_days": 6,
"source": "Quiver Quantitative",
"snippet": "VRTX rises after CASGEVY label expansion broadens patient reach Quiver Quantitative",
"relevance": 1.0,
"category": "市场观点",
"sentiment": "neutral",
"freshness": 0.65,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "Vertex Pharmaceuticals: Povetacicept May Redefine Growth Narrative (Rating Upgrade) (VRTX)",
"link": "https://news.google.com/rss/articles/CBMivgFBVV95cUxOaXd1cVRJTG5BTTlvSWRTSTVaRDZBOFJZT1dicm1FMUNsb21LVXdPN2tJZnYzVjRlRjRRbzZreC14UmUtajd6UnRNQm5yMlNEaHJGVXE5bnFYTzdRS2RpT3ZXVWlqQlZTTzcwVWYtOVlrMkFuclJtMFVXby1OY3RlbnpYbUJsQUMzSG40bGRISVlLekRvUjBaaVVBMXhsNnNYSzBISzdQaEhUQzZBb1k5WXgzVzBPZkRLZTlaZWtB?oc=5",
"published": "2026-06-24",
"age_days": 15,
"source": "Seeking Alpha",
"snippet": "Vertex Pharmaceuticals: Povetacicept May Redefine Growth Narrative (Rating Upgrade) (VRTX) Seeking Alpha",
"relevance": 1.7,
"category": "分析师/评级",
"sentiment": "positive",
"freshness": 0.3,
"positive_hits": 2.0,
"negative_hits": 0.0
},
{
"title": "Positive Pediatric CASGEVY Data Might Change The Case For Investing In Vertex Pharmaceuticals (VRTX)",
"link": "https://news.google.com/rss/articles/CBMinwFBVV95cUxPNzJydi1RUXhvaVExQVVJWnhpYjEyb3NOVHJheExOYmsyLU5famxjRnRWdS1TSDJLWjZNUmtEa3RLNkZxaGVtYWNPSmFLSFJnNktJWDVHSk9DVFlmVVdLLWRmWHdiR19LZXpWZm9MWlU4VkVOOGp0QktVX3ZmdWtiZ25BSS05SzVqaEtacm9fSGI4bzcyMVN0RTNIWWFCaTA?oc=5",
"published": "2026-06-23",
"age_days": 16,
"source": "Yahoo Finance",
"snippet": "Positive Pediatric CASGEVY Data Might Change The Case For Investing In Vertex Pharmaceuticals (VRTX) Yahoo Finance",
"relevance": 2.0,
"category": "市场观点",
"sentiment": "neutral",
"freshness": 0.3,
"positive_hits": 0.0,
"negative_hits": 0.0
}
],
"news_score": 0.977,
"positive_hits": 3.6,
"negative_hits": 0.0,
"news_sources": [
"CNN",
"Quiver Quantitative",
"RTTNews",
"Seeking Alpha",
"Yahoo Finance",
"Zacks"
],
"catalysts": [
"业绩/指引",
"产品/订单",
"医药/审批",
"市场观点"
],
"news_errors": []
},
{
"symbol": "JNJ",
"name": "Johnson & Johnson Common Stock",
"sector": "Health Care",
"industry": "Biotechnology: Pharmaceutical Preparations",
"exchange": "NYSE",
"market_cap": 634060950161.0,
"dollar_volume": 1782786023.9999998,
"price": 263.3999938964844,
"last_date": "2026-07-08",
"return_1d": -0.014369093242829645,
"return_5d": 0.03713034071132859,
"return_20d": 0.13456232659197553,
"return_60d": 0.10458771483866958,
"return_120d": 0.2328574838345392,
"ma20_distance": 0.07105822797046635,
"ma50_distance": 0.12156788916923045,
"ma200_distance": 0.19593569729950944,
"high_52w": 267.239990234375,
"near_52w_high": 0.9856309067571704,
"volume_ratio": 0.8600939054028575,
"volume_ratio_1d": 0.7829383206456546,
"volatility_20d": 0.30129570683647094,
"drawdown_52w": -0.014369093242829645,
"trend_score": 1.0,
"sector_score": 0.9230769230769231,
"rs_20d": 0.1262020901862151,
"rs_60d": -0.059665143122224595,
"entry_setup_score": 1.0,
"overheat_score": 0.0,
"macro_fit": 0.6904379247867379,
"research_score": 61.4709858103062,
"heat_score": 45.48543689320388,
"breakdown": {
"research_quality": 61.4709858103062,
"market_heat": 45.48543689320388,
"macro_event": 9.66613094701433,
"entry_setup": 7.0,
"overheat_penalty": -0.0,
"near_52w_high": 3.8135922330097087,
"news": 9.35,
"relative_strength": 10.205825242718447,
"volume": 3.4485436893203882,
"liquidity": 5.405825242718446
},
"score": 53.7844482986239,
"is_near_high": true,
"is_high_volume": false,
"items": [
{
"title": "The Case For Buying Smaller Dividends That Grow Faster",
"link": "https://247wallst.com/personal-finance/2026/07/09/the-case-for-buying-smaller-dividends-that-grow-faster/?.tsrc=rss",
"published": "2026-07-09",
"age_days": 0,
"source": "Yahoo Finance",
"snippet": "A share of Johnson & Johnson (NYSE: JNJ) paid $0.25 per quarter in dividends in 1999. That same share pays $1.34 per quarter in 2026. The stock price has moved through plenty of cycles since then, but the income stream alone has more than quintupled without the investor doing anything except holding. That trajectory is ... The Case For Buying Smaller Dividends That Grow Faster",
"relevance": 2.3,
"category": "业绩/指引",
"sentiment": "neutral",
"freshness": 1.0,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "Dual-Energy EP Catheter Approval Could Be A Game Changer For Johnson & Johnson (JNJ)",
"link": "https://finance.yahoo.com/healthcare/articles/dual-energy-ep-catheter-approval-011235811.html?.tsrc=rss",
"published": "2026-07-09",
"age_days": 0,
"source": "Yahoo Finance",
"snippet": "Johnson & Johnson recently received U.S. FDA approval for its Dual Energy THERMOCOOL SMARTTOUCH SF Platform, an ablation catheter that can deliver both radiofrequency and pulsed field energy through a single device, integrated with the CARTO mapping ecosystem, with U.S. procedures set to begin following a phased commercial rollout this summer. This dual-energy, single-catheter approach could deepen Johnson & Johnson’s position in advanced electrophysiology by simplifying workflows for...",
"relevance": 2.0,
"category": "医药/审批",
"sentiment": "positive",
"freshness": 1.0,
"positive_hits": 1.0,
"negative_hits": 0.0
},
{
"title": "Johnson & Johnson (JNJ) Declines More Than Market: Some Information for Investors",
"link": "https://finance.yahoo.com/markets/stocks/articles/johnson-johnson-jnj-declines-more-214504944.html?.tsrc=rss",
"published": "2026-07-08",
"age_days": 0,
"source": "Yahoo Finance",
"snippet": "Johnson & Johnson (JNJ) closed at $263.4 in the latest trading session, marking a -1.44% move from the prior day.",
"relevance": 2.0,
"category": "市场观点",
"sentiment": "neutral",
"freshness": 1.0,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "Unusual Put Option Activity in Johnson & Johnson After JNJ Stock's Recent Runup",
"link": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQMXFRdk5zbG1kZzJXWGVIeWx0MGdld1EyZFhhZW5FRlNGcXFiTWxUajdhek5NWU51RFlNMXl1cks4V3VBWXRmMGMyUkZRN1o0bWNWVmtnN2duV1ZEbXpPd0NvNkpteEwybi1ERnZwbUhscUxDRnpnQnkwYy1EdGxDMEcyYUJNcGItUXBWU0g2YXlaU1NrdU1ReW9WVXlLVFdndFdxMXNwOGIyaVFuWldSZDcxWng2ZloyMjUxVV93?oc=5",
"published": "2026-07-07",
"age_days": 1,
"source": "Barchart.com",
"snippet": "Unusual Put Option Activity in Johnson & Johnson After JNJ Stock's Recent Runup Barchart.com",
"relevance": 2.0,
"category": "市场观点",
"sentiment": "neutral",
"freshness": 1.0,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "Johnson & Johnson Wins FDA Approval For Dual Energy THERMOCOOL SMARTTOUCH SF Platform",
"link": "https://www.nasdaq.com/articles/johnson-johnson-wins-fda-approval-dual-energy-thermocool-smarttouch-sf-platform",
"published": "2026-07-08",
"age_days": 1,
"source": "RTTNews",
"snippet": "(RTTNews) - Johnson & Johnson (JNJ) announced that the U.S. FDA has approved its Dual Energy THERMOCOOL SMARTTOUCH SF Platform, an advanced catheter ablation solution that combines radiofrequency (RF) and pulsed field (PF) energy in a single device.",
"relevance": 1.7,
"category": "医药/审批",
"sentiment": "positive",
"freshness": 1.0,
"positive_hits": 2.0,
"negative_hits": 0.0
},
{
"title": "Johnson & Johnson, IBD Stock Of The Day, In Buy Zone Heading Into Earnings",
"link": "https://news.google.com/rss/articles/CBMioAFBVV95cUxNREF6MTF6N3ZmWF9iYlFEcVcyRmluLVZFYVNqamlIckdidEVRbWZzdUpuSmczb09tRkFwUnFOTkdEdFlJUWdySFhuMjNRNjA1VnhoWmhxWEhPRzg3eldHSEdqQlZJbks3bmRoOVdKODc2dzFraldGbVNxWDh0Tm5sVkY4bGhMdEdnTWQ4Q1ZaRDBDNjJQaVhHbVpSUWFUR2xL?oc=5",
"published": "2026-07-06",
"age_days": 2,
"source": "Investor's Business Daily",
"snippet": "Johnson & Johnson, IBD Stock Of The Day, In Buy Zone Heading Into Earnings Investor's Business Daily",
"relevance": 1.0,
"category": "业绩/指引",
"sentiment": "neutral",
"freshness": 1.0,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "JNJ Stock Management Sees A Breakout, The Market Sees A Standoff",
"link": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxOeHItencwTlJaeDJJLWZLUmZIUjR0bUwwVUkyOVhJUHJtdjhYOEZwUW9VZDJ1NF96UnhUckQwa2V6MWJmaXdObDZ3N01mdnNKZDFwQVlIOVhvUU5SMDVjdFZ4bWpzMjNJd2stM3B0UzBMZ2NkS3Z4TUl0a1k0OEp0ZloxSjJDeFY5c2NXTERGTjF3SXJEcmd2ZFdXZXlEaTFfeWI2dGY0VkttaVFGVHpXajdJNVFXaGt1QW93bkM4d3k?oc=5",
"published": "2026-07-02",
"age_days": 6,
"source": "Trefis",
"snippet": "JNJ Stock Management Sees A Breakout, The Market Sees A Standoff Trefis",
"relevance": 1.35,
"category": "市场观点",
"sentiment": "neutral",
"freshness": 0.65,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "Johnson & Johnson (JNJ) Stock After 73% One-Year Rally Is There Value Left",
"link": "https://news.google.com/rss/articles/CBMimAFBVV95cUxNMXRiN0hmU0xUMUpjVDVzTXAtZ2xOZHZpdENrWW9FMFhyMUJHVmVkY1l5V05WY0dqX1E2UnRhTUxNR0FfZExuNGNJdUlQNDNlcE5pQUtQNVVsN0NiazhJbXRzdXMxT2VPcWpEOGVBY213V2xEZHNfckpZTkpLWDZhNGJiZ3Nfc0pCbzIzcFVzVzBZdXFWNXZxUw?oc=5",
"published": "2026-06-30",
"age_days": 9,
"source": "Yahoo Finance",
"snippet": "Johnson & Johnson (JNJ) Stock After 73% One-Year Rally Is There Value Left Yahoo Finance",
"relevance": 2.3,
"category": "市场观点",
"sentiment": "neutral",
"freshness": 0.65,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "Why Johnson & Johnson Stock Popped on Friday",
"link": "https://news.google.com/rss/articles/CBMijgFBVV95cUxOWWJ3R0toU1JqV0o3ZUtzd1ItZlRrcmg4WER5ODRvNllyR2NZbUtvWl9feG1JbGpLZEVFY0V3UU1kMFdES1M4U2lhVVJUWmM0MUFpWEMyemtza0FQX3VBN1FIeHFTQkF6QkpEbVZiT1g4MHNVTlV3UDZTS3p6RmJldFppWnh1d2h0M09jM3NR?oc=5",
"published": "2026-06-26",
"age_days": 13,
"source": "The Motley Fool",
"snippet": "Why Johnson & Johnson Stock Popped on Friday The Motley Fool",
"relevance": 1.0,
"category": "市场观点",
"sentiment": "neutral",
"freshness": 0.3,
"positive_hits": 0.0,
"negative_hits": 0.0
}
],
"news_score": 0.9349999999999999,
"positive_hits": 3.0,
"negative_hits": 0.0,
"news_sources": [
"Barchart.com",
"Investor's Business Daily",
"RTTNews",
"The Motley Fool",
"Trefis",
"Yahoo Finance"
],
"catalysts": [
"业绩/指引",
"医药/审批",
"市场观点"
],
"news_errors": []
},
{
"symbol": "LLY",
"name": "Eli Lilly and Company Common Stock",
"sector": "Health Care",
"industry": "Biotechnology: Pharmaceutical Preparations",
"exchange": "NYSE",
"market_cap": 1144997453657.0,
"dollar_volume": 3170228091.7999997,
"price": 1215.8299560546875,
"last_date": "2026-07-08",
"return_1d": -0.01596854997200081,
"return_5d": 0.013673079387172216,
"return_20d": 0.05802543638688462,
"return_60d": 0.29416585305512966,
"return_120d": 0.12870526294317752,
"ma20_distance": 0.04875717127437085,
"ma50_distance": 0.1325963516067723,
"ma200_distance": 0.22583935939777633,
"high_52w": 1235.56005859375,
"near_52w_high": 0.9840314500279992,
"volume_ratio": 0.8323490800557034,
"volume_ratio_1d": 0.7803066880010215,
"volatility_20d": 0.33839139872694823,
"drawdown_52w": -0.01596854997200081,
"trend_score": 1.0,
"sector_score": 0.9230769230769231,
"rs_20d": 0.049665199981124175,
"rs_60d": 0.12991299509423548,
"entry_setup_score": 1.0,
"overheat_score": 0.0,
"macro_fit": 0.728594051958706,
"research_score": 61.557879014189695,
"heat_score": 40.780582524271836,
"breakdown": {
"research_quality": 61.557879014189695,
"market_heat": 40.780582524271836,
"macro_event": 10.200316727421884,
"entry_setup": 7.0,
"overheat_penalty": -0.0,
"near_52w_high": 3.774757281553398,
"news": 10.0,
"relative_strength": 10.605825242718447,
"volume": 2.920388349514563,
"liquidity": 5.67378640776699
},
"score": 53.002305084256676,
"is_near_high": true,
"is_high_volume": false,
"items": [
{
"title": "JPMorgan resets LLY stock target on drug demand",
"link": "https://www.thestreet.com/investing/stocks/jpmorgan-raises-eli-lilly-stock-price-target-1400?.tsrc=rss",
"published": "2026-07-09",
"age_days": 0,
"source": "Yahoo Finance",
"snippet": "Eli Lilly (LLY) keeps setting records, and Wall Street’s rating of its stock keeps increasing as well. On Tuesday, one of JPMorgan’s most closely watched healthcare stock analysts, Chris Schott, who frequently covers Pfizer Inc. (PFE), Eli Lilly, and Teva Pharmaceutical Industries Ltd. ...",
"relevance": 2.0,
"category": "分析师/评级",
"sentiment": "positive",
"freshness": 1.0,
"positive_hits": 1.0,
"negative_hits": 0.0
},
{
"title": "Innovent’s China Verzenios Deal and New Jaypirca Nod Might Change The Case For Investing In Eli Lilly (LLY)",
"link": "https://finance.yahoo.com/healthcare/articles/innovent-china-verzenios-deal-jaypirca-021211778.html?.tsrc=rss",
"published": "2026-07-09",
"age_days": 0,
"source": "Yahoo Finance",
"snippet": "In late June 2026, Innovent Biologics announced a distribution and promotion agreement giving it sole commercialization rights for Eli Lilly’s breast cancer drug Verzenios in mainland China, while Lilly retains manufacturing, supply and development responsibilities. At the same time, Eli Lilly received a positive regulatory opinion in Europe for expanding Jaypirca’s use in chronic lymphocytic leukemia, underscoring how partnerships and oncology approvals are broadening the company’s reach...",
"relevance": 2.0,
"category": "产品/订单",
"sentiment": "positive",
"freshness": 1.0,
"positive_hits": 1.0,
"negative_hits": 0.0
},
{
"title": "Stocks To Watch: 14 Names Test And Tease New Buy Zones",
"link": "https://finance.yahoo.com/m/1e048046-146b-3f8f-bcc2-0ba37935f0d0/stocks-to-watch%3A-14-names.html?.tsrc=rss",
"published": "2026-07-08",
"age_days": 0,
"source": "Yahoo Finance",
"snippet": "A barrage of stocks to watch like Eli Lilly and Deere, show promise, alongside reminders to keep risk management in mind.",
"relevance": 2.0,
"category": "市场观点",
"sentiment": "neutral",
"freshness": 1.0,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "Is It Too Late to Buy Eli Lilly?",
"link": "https://www.fool.com/investing/2026/07/08/is-it-too-late-to-buy-eli-lilly/?.tsrc=rss",
"published": "2026-07-08",
"age_days": 0,
"source": "Yahoo Finance",
"snippet": "The stock has soared 400% in recent years.",
"relevance": 2.0,
"category": "市场观点",
"sentiment": "neutral",
"freshness": 1.0,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "Texas Instruments Stock Is Running On A Bold Promise",
"link": "https://www.trefis.com/articles/606185/texas-instruments-stock-is-running-on-a-bold-promise/2026-07-08?.tsrc=rss",
"published": "2026-07-08",
"age_days": 0,
"source": "Yahoo Finance",
"snippet": "The chipmaker signaled a major turn in its business, and the market bought it. Now comes the hard part: proving the rally can last.",
"relevance": 1.6500000000000001,
"category": "市场观点",
"sentiment": "neutral",
"freshness": 1.0,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "LLY Hits Another Record High: Is the Stock Too Expensive to Buy Now?",
"link": "https://www.nasdaq.com/articles/lly-hits-another-record-high-stock-too-expensive-buy-now",
"published": "2026-07-08",
"age_days": 1,
"source": "Zacks",
"snippet": "Eli Lilly hits another record high as confidence grows in its obesity and diabetes portfolio, with Wall Street still seeing upside despite the rich valuation.",
"relevance": 1.7,
"category": "市场观点",
"sentiment": "positive",
"freshness": 1.0,
"positive_hits": 1.0,
"negative_hits": 0.0
},
{
"title": "Prediction: Eli Lilly Stock Will Hit This Price by the End of 2026",
"link": "https://www.nasdaq.com/articles/prediction-eli-lilly-stock-will-hit-price-end-2026",
"published": "2026-07-08",
"age_days": 1,
"source": "The Motley Fool",
"snippet": "Key PointsEli Lilly's new oral obesity drug, Foundayo, removes many of the barriers that have limited GLP-1 adoption, potentially expanding the addressable market well beyond injectable treatments.",
"relevance": 1.7,
"category": "医药/审批",
"sentiment": "neutral",
"freshness": 1.0,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "LLY Stock Quote Price and Forecast",
"link": "https://news.google.com/rss/articles/CBMiT0FVX3lxTE9BaS1CbmRhaWdiSHo1UVJLMVlDQ3ZYN3ZCaEg4QUtoUmJKeEw2R1Ryek03SjhFdFd5R1RLV3BXaFRGcUFjVHdjdHNzTExNN2s?oc=5",
"published": "2026-07-08",
"age_days": 1,
"source": "CNN",
"snippet": "LLY Stock Quote Price and Forecast CNN",
"relevance": 1.35,
"category": "市场观点",
"sentiment": "neutral",
"freshness": 1.0,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "Why Eli Lilly Stock Climbed to a Record High Today",
"link": "https://www.nasdaq.com/articles/why-eli-lilly-stock-climbed-record-high-today",
"published": "2026-07-07",
"age_days": 2,
"source": "The Motley Fool",
"snippet": "Key PointsEli Lilly's shareholders are in store for even more gains, according to a respected investment bank.",
"relevance": 1.7,
"category": "市场观点",
"sentiment": "positive",
"freshness": 1.0,
"positive_hits": 1.0,
"negative_hits": 0.0
}
],
"news_score": 1.0,
"positive_hits": 4.0,
"negative_hits": 0.0,
"news_sources": [
"CNN",
"The Motley Fool",
"Yahoo Finance",
"Zacks"
],
"catalysts": [
"产品/订单",
"分析师/评级",
"市场观点"
],
"news_errors": []
},
{
"symbol": "PM",
"name": "Philip Morris International Inc Common Stock",
"sector": "Health Care",
"industry": " Medicinal Chemicals and Botanical Products ",
"exchange": "NYSE",
"market_cap": 291559603321.0,
"dollar_volume": 661632730.3299999,
"price": 187.07000732421875,
"last_date": "2026-07-08",
"return_1d": -0.003833995354678099,
"return_5d": 0.034050099703798464,
"return_20d": 0.0625355555963858,
"return_60d": 0.16590845049728253,
"return_120d": 0.12794694265768447,
"ma20_distance": 0.03241797511390665,
"ma50_distance": 0.04451897591511411,
"ma200_distance": 0.11705627485081527,
"high_52w": 191.86000061035156,
"near_52w_high": 0.9750339139430068,
"volume_ratio": 0.8933609275136863,
"volume_ratio_1d": 0.724724240085243,
"volatility_20d": 0.27076102753320547,
"drawdown_52w": -0.024966086056993242,
"trend_score": 1.0,
"sector_score": 0.9230769230769231,
"rs_20d": 0.05417531919062535,
"rs_60d": 0.0016555925363883617,
"entry_setup_score": 1.0,
"overheat_score": 0.0,
"macro_fit": 0.7494284815363919,
"research_score": 60.34950522778192,
"heat_score": 41.599999999999994,
"breakdown": {
"research_quality": 60.34950522778192,
"market_heat": 41.599999999999994,
"macro_event": 10.491998741509486,
"entry_setup": 7.0,
"overheat_penalty": -0.0,
"near_52w_high": 3.6427184466019416,
"news": 9.9625,
"relative_strength": 9.759223300970874,
"volume": 4.14757281553398,
"liquidity": 4.054368932038835
},
"score": 52.988961124995754,
"is_near_high": true,
"is_high_volume": false,
"items": [
{
"title": "UBS Lifts Philip Morris International (PM) Price Target by $14",
"link": "https://finance.yahoo.com/markets/stocks/articles/ubs-lifts-philip-morris-international-050604699.html?.tsrc=rss",
"published": "2026-07-08",
"age_days": 1,
"source": "Yahoo Finance",
"snippet": "With an annual dividend yield of 3.23%, Philip Morris International Inc. (NYSE:PM) is included among the 14 Best Blue Chip Dividend Stocks to Buy According to Hedge Funds. Philip Morris International Inc. (NYSE:PM) operates as a global tobacco company. Its products include cigarettes and smoke-free alternatives. Its smoke-free business also covers wellness and healthcare products, along […]",
"relevance": 2.3,
"category": "分析师/评级",
"sentiment": "neutral",
"freshness": 1.0,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "Altria vs. Philip Morris International: Tobacco Still Makes a Great Stock. Which Is a Better Buy in 2026?",
"link": "https://www.fool.com/coverage/better-buy/2026/07/06/altria-vs-philip-morris-international-tobacco-still-makes-a-great-stock-which-is-a-better-buy-in-2026/?.tsrc=rss",
"published": "2026-07-06",
"age_days": 2,
"source": "Yahoo Finance",
"snippet": "Domestic cash machine vs. global growth play, one trades at half the valuation multiple.",
"relevance": 1.3,
"category": "市场观点",
"sentiment": "positive",
"freshness": 1.0,
"positive_hits": 1.0,
"negative_hits": 0.0
},
{
"title": "PMI U.S. Unveils the ZYN America250 Art Series, Bringing Modern Culture to Limited-Edition Cases",
"link": "https://finance.yahoo.com/media-advertising/articles/pmi-u-unveils-zyn-america250-120000843.html?.tsrc=rss",
"published": "2026-07-03",
"age_days": 5,
"source": "Yahoo Finance",
"snippet": "Philip Morris International's U.S. businesses (PMI U.S.) today announced the launch of the ZYN America250 Art Series, a cultural initiative from America's No. 1 nicotine pouch brand, celebrating the nation's 250th anniversary through the lens of contemporary American art and creative expression.",
"relevance": 2.3,
"category": "分析师/评级",
"sentiment": "positive",
"freshness": 0.65,
"positive_hits": 1.0,
"negative_hits": 0.0
},
{
"title": "Philip Morris’ Smoke-Free Products Are Winning With Regulators. They’ll Win With Investors Too.",
"link": "https://finance.yahoo.com/m/d7f8116f-9a33-3fdb-8dab-9bb09f7674ea/philip-morris%E2%80%99-smoke-free.html?.tsrc=rss",
"published": "2026-07-02",
"age_days": 6,
"source": "Yahoo Finance",
"snippet": "Margin expansion, sales growth, and a reliable dividend payment make the stock a good bet for volatile times.",
"relevance": 1.0,
"category": "监管/法律",
"sentiment": "positive",
"freshness": 0.65,
"positive_hits": 1.0,
"negative_hits": 0.0
},
{
"title": "Philip Morris International Inc. stock outperforms competitors on strong trading day",
"link": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxPTExaRGNFRE1Jc1BsdzltZkNCdjJ4LVI4My1XWkpWejE1aXBNemRHRTNtc002RDQ1VlRWWlZ4eFNmYzlXZ1FkWldsNlpWY2lER1Zaa2RxT1BaSUJnRThVeHFUM2xWT0hnRkM3Wmt4WU1ZSFRWSXRkUF9mN1p1Mmh4T3p4clh5cDdQODdIMUVzSXNtVjJ5c1RLSGhiRkpIdFk3OGU0Ul9zQzlOVnVpT3dscHBfWUpyNnIzTzB2cjJRckxQekVpSnBqNkNGb184UlE0RFlvdVY4ZTlESDg?oc=5",
"published": "2026-07-02",
"age_days": 6,
"source": "MarketWatch",
"snippet": "Philip Morris International Inc. stock outperforms competitors on strong trading day MarketWatch",
"relevance": 1.0,
"category": "分析师/评级",
"sentiment": "positive",
"freshness": 0.65,
"positive_hits": 2.0,
"negative_hits": 0.0
},
{
"title": "Philip Morris International Gains First FDA MRTP Orders For ZYN Nicotine Pouches",
"link": "https://www.nasdaq.com/articles/philip-morris-international-gains-first-fda-mrtp-orders-zyn-nicotine-pouches",
"published": "2026-06-30",
"age_days": 9,
"source": "RTTNews",
"snippet": "(RTTNews) - Philip Morris International Inc. (PM) announced that the U.S. Food and Drug Administration (FDA) has issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products, marking the first time nicotine pouches have received such authoriza",
"relevance": 2.0,
"category": "产品/订单",
"sentiment": "neutral",
"freshness": 0.65,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "DGRO, HD, PM, KO: ETF Outflow Alert",
"link": "https://www.nasdaq.com/articles/dgro-hd-pm-ko-etf-outflow-alert",
"published": "2026-06-30",
"age_days": 9,
"source": "BNK Invest",
"snippet": "Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Core Dividend Growth ETF (Symbol: DGRO) where we have detected an approximate $1.3 billion dollar outflow -- that's a 3.0% decrease week ove",
"relevance": 1.0,
"category": "并购/资本",
"sentiment": "positive",
"freshness": 0.65,
"positive_hits": 1.0,
"negative_hits": 0.0
},
{
"title": "Altria vs. Philip Morris International: Which Consumer Goods Stock Is a Better Buy in 2026?",
"link": "https://www.nasdaq.com/articles/altria-vs-philip-morris-international-which-consumer-goods-stock-better-buy-2026",
"published": "2026-06-30",
"age_days": 9,
"source": "The Motley Fool",
"snippet": "Key PointsAltria maintains a dominant position in the U.S. tobacco market with industry-leading net margins and a massive domestic distribution network.",
"relevance": 1.0,
"category": "市场观点",
"sentiment": "neutral",
"freshness": 0.65,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "Philip Morris International (PM) Stock After 11.5% YTD Gain Are Valuation Concerns Justified",
"link": "https://news.google.com/rss/articles/CBMiowFBVV95cUxNUXFlMHV2eDlTMFk2Q2NmRHFRdldtX1lCUGhrUVpvMDhxVGhWZk9zVUNrTDBkZGZzNXlycTd1eWlEbEYtREpMNWpuZWlDblhPdW9EUC11VnZwV1JLclBDNFI4aEJoUmZlVzE5Z0lZdFdHNWVwRDY2LVg0MHlvbDFXZm5MTTZYQjFPU191QjREenRJVmwtdmdnMzhQazJHRjZpVDk4?oc=5",
"published": "2026-06-24",
"age_days": 15,
"source": "Yahoo Finance",
"snippet": "Philip Morris International (PM) Stock After 11.5% YTD Gain Are Valuation Concerns Justified Yahoo Finance",
"relevance": 2.3,
"category": "市场观点",
"sentiment": "neutral",
"freshness": 0.3,
"positive_hits": 0.0,
"negative_hits": 0.0
}
],
"news_score": 0.9962500000000001,
"positive_hits": 4.25,
"negative_hits": 0.0,
"news_sources": [
"BNK Invest",
"MarketWatch",
"RTTNews",
"The Motley Fool",
"Yahoo Finance"
],
"catalysts": [
"分析师/评级",
"市场观点",
"监管/法律"
],
"news_errors": []
},
{
"symbol": "MNST",
"name": "Monster Beverage Corporation",
"sector": "Consumer Staples",
"industry": "Beverages (Production/Distribution)",
"exchange": "NASDAQ",
"market_cap": 93057471667.0,
"dollar_volume": 505955843.25000006,
"price": 95.1500015258789,
"last_date": "2026-07-08",
"return_1d": -0.018262450232211624,
"return_5d": -0.010091564637805028,
"return_20d": 0.07550582358998059,
"return_60d": 0.256603275118058,
"return_120d": 0.21318374545001406,
"ma20_distance": 0.008388238666358738,
"ma50_distance": 0.07771559996761801,
"ma200_distance": 0.2189935114653936,
"high_52w": 97.63999938964844,
"near_52w_high": 0.9744981782124682,
"volume_ratio": 0.9447764039256674,
"volume_ratio_1d": 0.8738586838628252,
"volatility_20d": 0.16797156927230478,
"drawdown_52w": -0.025501821787531798,
"trend_score": 1.0,
"sector_score": 0.6923076923076923,
"rs_20d": 0.06714558718422015,
"rs_60d": 0.09235041715716386,
"entry_setup_score": 1.0,
"overheat_score": 0.0,
"macro_fit": 0.7558147804215984,
"research_score": 61.242268483943235,
"heat_score": 39.71456310679612,
"breakdown": {
"research_quality": 61.242268483943235,
"market_heat": 39.71456310679612,
"macro_event": 10.581406925902378,
"entry_setup": 7.0,
"overheat_penalty": -0.0,
"near_52w_high": 3.6116504854368934,
"news": 9.7525,
"relative_strength": 10.827184466019418,
"volume": 4.9864077669902915,
"liquidity": 3.3669902912621357
},
"score": 52.9502054228242,
"is_near_high": true,
"is_high_volume": false,
"items": [
{
"title": "Monster Beverage Declares Two-for-One Stock Split",
"link": "https://finance.yahoo.com/markets/stocks/articles/monster-beverage-declares-two-one-201000064.html?.tsrc=rss",
"published": "2026-07-08",
"age_days": 0,
"source": "Yahoo Finance",
"snippet": "CORONA, Calif., July 08, 2026 (GLOBE NEWSWIRE) -- Monster Beverage Corporation (NASDAQ: MNST) today announced that its Board of Directors has approved and declared a 2-for-1 split of its common stock that will be effected in the form of a 100% stock dividend. Each stockholder of record on July 24, 2026 will receive a dividend of one additional share of common stock for each then-held share, to be distributed after close of trading on August 10, 2026. The Company anticipates its common stock to b",
"relevance": 2.3,
"category": "并购/资本",
"sentiment": "positive",
"freshness": 1.0,
"positive_hits": 2.0,
"negative_hits": 0.0
},
{
"title": "Monster Beverage to double shares in 2-for-1 stock split",
"link": "https://news.google.com/rss/articles/CBMinwFBVV95cUxQUGF5V01mZWRfQ0FLUlI3Y29oYnRGdTdNWElEVWFFbjdGaXhBSlBqSURkd0xLeHpraThxYm5RSHZPZUxyNkVZVEEteHBZS1hveGRpSnRPbEUzMVJJMUtWWXl3c1gyQWZDRXhsVjhlQnZQSzZyOHFUakNHS2V5UFVHNVdicUllSG5maWZrYTBXRDJPYmFiSUJvMDFUNVlxYWc?oc=5",
"published": "2026-07-08",
"age_days": 0,
"source": "Stock Titan",
"snippet": "Monster Beverage to double shares in 2-for-1 stock split Stock Titan",
"relevance": 0.7,
"category": "市场观点",
"sentiment": "neutral",
"freshness": 1.0,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "Morgan Stanley unveils key Monster stock price prediction",
"link": "https://www.thestreet.com/investing/stocks/morgan-stanley-unveils-key-monster-stock-prediction?.tsrc=rss",
"published": "2026-07-05",
"age_days": 4,
"source": "Yahoo Finance",
"snippet": "Monster Beverage (MNST) shares have spent the summer moving toward record highs, and Morgan Stanley just gave investors a fresh reason to keep watching. The bank reiterated its Overweight rating and $103 price target on the energy drink maker this week. Morgan Stanley is standing by a call it has ...",
"relevance": 2.0,
"category": "分析师/评级",
"sentiment": "positive",
"freshness": 0.65,
"positive_hits": 1.0,
"negative_hits": 0.0
},
{
"title": "Will Monster Beverage's Expansion Strategy & Innovations Aid?",
"link": "https://finance.yahoo.com/markets/stocks/articles/monster-beverages-expansion-strategy-innovations-153500418.html?.tsrc=rss",
"published": "2026-07-03",
"age_days": 5,
"source": "Yahoo Finance",
"snippet": "MNST is riding strong energy drink demand and product innovation to fuel growth while expanding its global footprint and market share.",
"relevance": 2.0,
"category": "市场观点",
"sentiment": "positive",
"freshness": 0.65,
"positive_hits": 2.0,
"negative_hits": 0.0
},
{
"title": "FMX or MNST: Which Is the Better Value Stock Right Now?",
"link": "https://finance.yahoo.com/markets/stocks/articles/fmx-mnst-better-value-stock-154001845.html?.tsrc=rss",
"published": "2026-07-03",
"age_days": 5,
"source": "Yahoo Finance",
"snippet": "FMX vs. MNST: Which Stock Is the Better Value Option?",
"relevance": 1.3,
"category": "市场观点",
"sentiment": "neutral",
"freshness": 0.65,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "Should Investors Buy Celsius Stock Instead of Monster Stock?",
"link": "https://www.nasdaq.com/articles/should-investors-buy-celsius-stock-instead-monster-stock",
"published": "2026-07-02",
"age_days": 7,
"source": "The Motley Fool",
"snippet": "The energy drink segment is growing faster than the overall beverage market.",
"relevance": 0.7,
"category": "市场观点",
"sentiment": "neutral",
"freshness": 0.65,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "Monster Beverage stock hits 52-week high at $97.89 By Investing.com",
"link": "https://news.google.com/rss/articles/CBMirAFBVV95cUxPdExZeTYtaTExUng5Skp0QURnSDh0bHNNRUVFVTVlSVRHQi1IT2k2WWVnc1MzMlVlVWJXaDI0WlJCNnVTdjVNT0k1cFgyNVpqbVBhbzF4eFE2S0VlSGRFYTByRDlKLVN2YTVrdkx0cmpGRzN0aXQtZGpVS2tNUFZFclRBSkNlSDdPNGVSMjA2UE5lWDNGdVNKMmlIeFRnTjdMWlA5TTVsaURPMWpj?oc=5",
"published": "2026-07-01",
"age_days": 7,
"source": "Investing.com Nigeria",
"snippet": "Monster Beverage stock hits 52-week high at $97.89 By Investing.com Investing.com Nigeria",
"relevance": 0.7,
"category": "市场观点",
"sentiment": "neutral",
"freshness": 0.65,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "Monster Beverage Stock Has Outrun the Street’s Mean Target. Here’s the Fuller Picture",
"link": "https://news.google.com/rss/articles/CBMirAFBVV95cUxQTjZXN1k4RDF3OHFYWWdYSV9qRDFmV194Zk5DSXhaR0RCTkxfSXBzS1IxaW9KS0dVZWZwYzdUSjhFT3htTVd5WEpiUm4xbU5YNjFJSTdJXzB4eDRadldtc0ZIOUtoUmNEUkxlTG9TNzhKbGs3cU5vQ05pdjFuUjVKOW8wZW9lXzUxakVJX2ZDWF90WnRnUy1qQkNsUjNidlF6RDJ0MF9IZFVKVEVj?oc=5",
"published": "2026-06-29",
"age_days": 9,
"source": "TIKR.com",
"snippet": "Monster Beverage Stock Has Outrun the Street’s Mean Target. Here’s the Fuller Picture TIKR.com",
"relevance": 0.7,
"category": "市场观点",
"sentiment": "neutral",
"freshness": 0.65,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "JQUA, CB, KEYS, MNST: Large Inflows Detected at ETF",
"link": "https://www.nasdaq.com/articles/jqua-cb-keys-mnst-large-inflows-detected-etf",
"published": "2026-06-29",
"age_days": 10,
"source": "BNK Invest",
"snippet": "Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the JPMorgan US Quality Factor ETF (Symbol: JQUA) where we have detected an approximate $509.0 million dollar inflow -- that's a 6.4% increase week over",
"relevance": 1.0,
"category": "市场观点",
"sentiment": "neutral",
"freshness": 0.65,
"positive_hits": 0.0,
"negative_hits": 0.0
}
],
"news_score": 0.97525,
"positive_hits": 3.95,
"negative_hits": 0.0,
"news_sources": [
"BNK Invest",
"Investing.com Nigeria",
"Stock Titan",
"TIKR.com",
"The Motley Fool",
"Yahoo Finance"
],
"catalysts": [
"分析师/评级",
"市场观点",
"并购/资本"
],
"news_errors": []
},
{
"symbol": "JPM",
"name": "JP Morgan Chase & Co. Common Stock",
"sector": "Finance",
"industry": "Major Banks",
"exchange": "NYSE",
"market_cap": 885900065019.0,
"dollar_volume": 6117225797.32,
"price": 330.6199951171875,
"last_date": "2026-07-08",
"return_1d": -0.025352296658711193,
"return_5d": 0.010051045366708422,
"return_20d": 0.06271097259568248,
"return_60d": 0.06696356642130752,
"return_120d": 0.06342876039833234,
"ma20_distance": 0.007783460726068947,
"ma50_distance": 0.05258531131820132,
"ma200_distance": 0.07046405172181425,
"high_52w": 339.2200012207031,
"near_52w_high": 0.9746477033412888,
"volume_ratio": 1.1314941931400024,
"volume_ratio_1d": 1.807389447916046,
"volatility_20d": 0.24407385762220532,
"drawdown_52w": -0.025352296658711193,
"trend_score": 1.0,
"sector_score": 0.8461538461538461,
"rs_20d": 0.05435073618992203,
"rs_60d": -0.09728929153958665,
"entry_setup_score": 0.959261145066586,
"overheat_score": 0.0,
"macro_fit": 0.5589867261258263,
"research_score": 62.382042354525105,
"heat_score": 46.019417475728154,
"breakdown": {
"research_quality": 62.382042354525105,
"market_heat": 46.019417475728154,
"macro_event": 7.825814165761569,
"entry_setup": 6.714828015466102,
"overheat_penalty": -0.0,
"near_52w_high": 3.6194174757281554,
"news": 10.0,
"relative_strength": 8.32621359223301,
"volume": 7.052427184466019,
"liquidity": 5.836893203883495
},
"score": 52.357601155228224,
"is_near_high": true,
"is_high_volume": true,
"items": [
{
"title": "JPMorgan (JPM) Ranks Among the Most Profitable Stocks",
"link": "https://finance.yahoo.com/markets/stocks/articles/jpmorgan-jpm-ranks-among-most-204117416.html?.tsrc=rss",
"published": "2026-07-08",
"age_days": 0,
"source": "Yahoo Finance",
"snippet": "JPMorgan Chase & Co. (NYSE:JPM) is one of the 12 Most Profitable Cheap Stocks to Buy Right Now. On June 29, Morgan Stanley increased its price target on JPMorgan Chase & Co. (NYSE:JPM) from $336 to $362 and maintained its Equal Weight rating on the stock. The research firm said it remains positive on the […]",
"relevance": 2.3,
"category": "分析师/评级",
"sentiment": "positive",
"freshness": 1.0,
"positive_hits": 1.0,
"negative_hits": 0.0
},
{
"title": "JPMorgan Chase & Co. (JPM) Registers a Bigger Fall Than the Market: Important Facts to Note",
"link": "https://finance.yahoo.com/markets/stocks/articles/jpmorgan-chase-co-jpm-registers-214505896.html?.tsrc=rss",
"published": "2026-07-08",
"age_days": 0,
"source": "Yahoo Finance",
"snippet": "In the most recent trading session, JPMorgan Chase & Co. (JPM) closed at $330.62, indicating a -2.54% shift from the previous trading day.",
"relevance": 2.0,
"category": "市场观点",
"sentiment": "neutral",
"freshness": 1.0,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "JPMorgan to pursue smaller deals in latest growth push",
"link": "https://finance.yahoo.com/markets/article/jpmorgan-to-pursue-smaller-deals-in-latest-growth-push-173733501.html?.tsrc=rss",
"published": "2026-07-08",
"age_days": 0,
"source": "Yahoo Finance",
"snippet": "The banking giant said Wednesday it's launching a dealmaking team catering to small-cap companies valued between $100 million and $500 million.",
"relevance": 1.6500000000000001,
"category": "产品/订单",
"sentiment": "positive",
"freshness": 1.0,
"positive_hits": 2.0,
"negative_hits": 0.0
},
{
"title": "Zacks Earnings Trends Highlights: JPM, BAC, C and WFC",
"link": "https://finance.yahoo.com/markets/stocks/articles/zacks-earnings-trends-highlights-jpm-062200857.html?.tsrc=rss",
"published": "2026-07-09",
"age_days": 0,
"source": "Yahoo Finance",
"snippet": "Q2 earnings season begins with major banks reporting July 14 as S&P 500 profit forecasts stay strong and Finance sector growth remains in focus.",
"relevance": 1.3,
"category": "业绩/指引",
"sentiment": "positive",
"freshness": 1.0,
"positive_hits": 3.0,
"negative_hits": 0.0
},
{
"title": "Strategy’s Preferred Shares Carry 10%-Plus Yields—and Lots of Risk",
"link": "https://finance.yahoo.com/m/d31f23dc-5a37-3534-a9fa-4e4658c324fb/strategy%E2%80%99s-preferred-shares.html?.tsrc=rss",
"published": "2026-07-09",
"age_days": 0,
"source": "Yahoo Finance",
"snippet": "Declining prices of Bitcoin and Strategy’s common stock have hurt the prices of its four preferred issues.",
"relevance": 1.0,
"category": "市场观点",
"sentiment": "neutral",
"freshness": 1.0,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "JPMorgan Chase (JPM) Stock Gets Fair Value Bump As Analysts Rework Revenue Outlook",
"link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxQZS1hR2RnSWpLSmd6UTQwSnR5YUFSM250Ri1KWERKbTVqRW4wVUdVREVwZ0Q0SlBiVkNmcjRuazhBNmJJbTE3eEpvNkdXZ2I5V2w1VzZPNjBHUG4yQmpPX1J4YzZacEkwV252d1Z3RmJlSm11N2FoZjF3TnhrQWY4UFRhYnZiTEJOZEZxQWRsZlQzbEZVcjZCSHd3?oc=5",
"published": "2026-07-02",
"age_days": 6,
"source": "Yahoo Finance",
"snippet": "JPMorgan Chase (JPM) Stock Gets Fair Value Bump As Analysts Rework Revenue Outlook Yahoo Finance",
"relevance": 2.3,
"category": "分析师/评级",
"sentiment": "neutral",
"freshness": 0.65,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "Is JPMorgan Chase & Co. (JPM) Stock Still a Banking Sector Leader Ahead of Earnings Season?",
"link": "https://news.google.com/rss/articles/CBMilwFBVV95cUxNOUM2WXhQWjVfSG9SU3QwajBuTHhVV3lPbkQwejl4eWNCMG1LWVVwY0NhMzNzNHhIcks4SHhlODBxODhRX3dvel9ORkdRTmgyYnZGUDB3SXlFbC10c0QzMGplR1JhZkdZaEZBRGRiMHR6QU5Gekt2RXV1MUFvYlZnQnpiMzliS2ZWR1U2V0p1Uktaek40Y3BV?oc=5",
"published": "2026-07-02",
"age_days": 6,
"source": "Yahoo Finance",
"snippet": "Is JPMorgan Chase & Co. (JPM) Stock Still a Banking Sector Leader Ahead of Earnings Season? Yahoo Finance",
"relevance": 2.3,
"category": "业绩/指引",
"sentiment": "neutral",
"freshness": 0.65,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "JPMorgan Chase (JPM) Stock After Regulatory Headlines Is The Recent 10% Rise Justified",
"link": "https://news.google.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?oc=5",
"published": "2026-06-30",
"age_days": 9,
"source": "simplywall.st",
"snippet": "JPMorgan Chase (JPM) Stock After Regulatory Headlines Is The Recent 10% Rise Justified simplywall.st",
"relevance": 2.0,
"category": "监管/法律",
"sentiment": "neutral",
"freshness": 0.65,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "JPMorgan (JPM) Stock Still Looks Cheap As Its 141% Run Continues",
"link": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNalM4RWZoM2FZY2ZwMEJMYjR3dS1fY3A2bTgzbjJiR3phSlhFWGVQMTFLdkJ3ZGs0QnEtNkNDVmx6elJxb2hxOUlIQTc1cWRhZ2E0VUlIbWczREY3UGtmVzFTYVBwYlRDd2FkVDY1S2xOcGpiR2R3bEo2NlNaLU51M2lYVkNucHRwQUJKeDd6MVlzVXhMRldzVWxwNA?oc=5",
"published": "2026-06-30",
"age_days": 9,
"source": "Yahoo Finance",
"snippet": "JPMorgan (JPM) Stock Still Looks Cheap As Its 141% Run Continues Yahoo Finance",
"relevance": 2.0,
"category": "市场观点",
"sentiment": "neutral",
"freshness": 0.65,
"positive_hits": 0.0,
"negative_hits": 0.0
}
],
"news_score": 1.0,
"positive_hits": 6.0,
"negative_hits": 0.0,
"news_sources": [
"Yahoo Finance",
"simplywall.st"
],
"catalysts": [
"业绩/指引",
"产品/订单",
"分析师/评级",
"市场观点"
],
"news_errors": []
}
],
"sources": [
"Nasdaq screener: exchange, sector, market cap, latest price and volume",
"Yahoo Finance chart endpoint: daily prices, volume, SPY/QQQ/VIX/^TNX macro tape",
"Yahoo Finance RSS / Nasdaq news / Google News RSS: company catalysts",
"Google News RSS: macro event headlines (FOMC, CPI/NFP, geopolitics, commodities)",
"Unified score: research quality + market heat + macro-event fit"
]
}